PUBLICATIONS FROM THE FINNISH CANCER REGISTRY 1953-2016 by M. Hakama 20.09.2016
2015 2014 2013 2012 and earlier
Lumme, S., Tenkanen, L., Langseth, H., Gislefoss, R., Hakama, M., Stattin, P., Hallmans, G., Adlercreutz, H., Saikku P., Stenman, U.-H., Tuohimaa, P., Luostrinen, T. and Dillner, J.: Longitudinal biobanks-based study on the joint effects of infections, nutrition and hormones on risk of prostate cancer. Acta Oncol. 2016; 55: 839-845.
Seppä, K., Pitkäniemi, J., Malila, N. and Hakama, M.: Age-related incidence of cervical cancer supports two aetiological components: a population-based register study. BJOG 2016; 123: 772-778.
Vohlonen, I., Pukkala, E., Malila, N., Härkönen, M., Hakama, M., Koistinen V. and Sipponen P.: Risk of gastric cancer in helicobacter pylori infection in a 15-year follow-up. Scand. J. Gastroenterol. 2016; 51: 1159-1164.
Hakama, M., Pokhrel, A., Malila, N. and Hakulinen, T.: Sensitivity, effect and overdiagnosis in screening for cancers with detectable pre-invasive phase. Int. J. Cancer 2015; 136: 928-935.
Kilpeläinen, T.P., Tammela, T.L.J., Malila, N., Hakama, M., Santti, H., Määttänen, L., Stenman, U.-H., Kujala, P. and Auvinen, A.: The Finnish prostate cancer screening trial: analyses on the screening failures. Int. J. Cancer 2015; 136: 2437-2443.
Mäklin, S., Hakama, M., Rissanen, P. and Malila, N.: Use of hospital resources in the Finnish colorectal cancer screening programme: a randomised health services study. BMJ Open Gastro, 2015;2:e000063.doi:10.1136/bmjgast-2015-000063.
Pitkäniemi, J., Seppä, K., Hakama, M., Malminiemi, O., Palva, T., Vuoristo, M.-S., Järvinen, H., Paimela, H., Pikkarainen, P., Anttila, A., Elovainio, L., Hakulinen, T., Karjalainen, S., Pylkkänen, L., Rautalahti, M., Sarkeala, T., Vertio, H. and Malila, N.: Effectiveness of screening for colorectal cancer with a faecal occult-blood test in Finland. BMJ Open Gastro 2015;2:e000034,doi:10.1136/bmjgast-2015-000034.
Thulaseedharan, J.V., Malila, N., Esmy, P.O., Muwonge, R., Hakama, M. and Sankaranarayanan, R.: Risk of invasive cancer among women visually screened and colposcopy triaged by trained nurses in rural south India. Int. J. Gynecol. Obstet 2015; 129: 104-108.
Thulaseedharan, J.V., Malila, N., Swaminathan, R., Esmy, P.O., Cherian, M., Hakama, M., Muwonge, R. and Sankaranarayanan, R.: Effect of screening on variation in cervical cancer survival by socioeconomic determinants - a study from rural south India. Asian Pac. J. Cancer Prev. 2015; 16: 5237-5242.
Thulaseedharan, J.V., Malila, N., Swaminathan, R., Esmy, P.O., Hakama, M., Muwonge, R. and Sankaranarayanan, R.: Survival of patients with cervical cancer in rural India. J. Clin. Gynecol. Obstet. 2015; 4: 290-296.
Auvinen, A. and Hakama, M.: Cancer screening. In: Theory and Applications, Reference Module in Biomedical Sciences. Elsevier. 17-Oct-2014 doi:10.1016/B978-0-12-801238-3.02744-6.
Helander, S., Hakama, M. and Malila, N.: Effect of a pre-screening survey on attendance in colorectal cancer screening: a double-randomized study in Finland. J. Med. Screen. 2014; 21: 82-88.
Huang, R.C.-C., Auvinen, A., Hakama, M., Tammela, T.L.J., Ala-Opas, M., Leppilahti, M., Vornanen, T. and Chen, H.-H.: Effect of intervention on decision making of treatment for disease progression, prostate-specific antigen biochemical failureand prostate cancer death. Health Expect. 2014; 17: 776-783.
Schröder, F.H., Hugosson, J., Roobol, M.J., Tammela, T.L.J., Zappa, M., Nelen, V., Kwiatkowski, M., Lujan, M., Määttänen, L., Lilja, H., Denis, L., Recker, F., Paez, A., Bangma, C.H., Carlsson, S., Puliti, D., Villers, A., Rebillard, X., Hakama, M., Stenman, U.-H., Kujala, P., Taari, K., Aus, G., Huber, A., van der Kwast, T.H., van Schaik, R.H.N., de Koning, H.J., Moss, S.M. and Auvinen, A. for the ERSPC Investigators:
Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up. Lancet 2014; 384: 2027-2035.
Hakama, M.: My fifty years. Acta Oncol. 2013; 52: 883-885.
Hakama, M.: Screening for cervical cancer. In: Epidemiologic Studies in Cancer Prevention and Screening. Statistics for Biology and Health. Ed. A.B. Miller. Springer Science+Business Media, New York 2013, pp. 223-232.
Kilpeläinen, T.P., Tammela, T.L., Malila, N., Hakama, M., Santti, H., Määttänen, L., Stenman, U.-H., Kujala, P. and Auvinen, A.: Prostate cancer mortality in the Finnish randomized screening trial. J. Natl. Cancer Inst. 2013; 105: 719-725.
Malila, N., Leinonen, M., Kotaniemi-Talonen, L., Laurila, P., Tarkkanen, J. and Hakama, M.: The HPV test has similar sensitivity but more overdiagnosis than the Pap test - A randomised health service study on cervical cancer screening in Finland. Int. J. Cancer 2013; 132: 2141-2147.
Malila, N., Leinonen, M., Kotaniemi-Talonen, L., Laurila, P., Tarkkanen, J. and Hakama, M.: HPV-testi on yhtä herkkä kuin papakoe, mutta ylidiagnostiikka on suurempaa. Duodecim 2013; 129: 365.The HPV test has similar sensitivity but more overdiagnosis than the Pap test - A randomised health service study on cervical cancer screening in Finland. Int. J. Cancer 2013; 132: 2141-2147. (in Finnish, with English summary)
Thulaseedharan, J.V., Malila, N., Hakama, M., Esmy, P.O., Cherian, M., Swaminathan, R., Muwonge, R. and Sankaranarayanan, R.: Effect of screening on the risk estimates of socio demographic factors on cervical cancer - a large cohort study from rural India. APJCP 2013; 14: 589-594.
Hakama, M., Malila, N. and Dillner, J.: Randomised health services studies. Int. J. Cancer 2012; 131: 2898-2902.
Leinonen, M.K., Nieminen, P., Lönnberg, S., Malila, N., Hakama, M., Pokhrel, A., Laurila, P., Tarkkanen, J. and Anttila, A.: Detection rates of precancerous and cancerous cervical lesions within one screening round of primary human papillomavirus DNA testing: prospective randomised trial in Finland. BMJ 2012;345:e7789.
Schröder, F.H., Hugosson, J., Roobol, M.J., Tammela, T.L.J., Ciatto, S., Nelen, V., Kwiatkowski, M., Lujan, M., Lilja, H., Zappa, M., Denis, L.J., Recker, F., Paez, A., Määttänen, L., Bangma, C.H., Aus, G., Carlsson, S., Villers, A., Rebillard, X., van der Kwast, T., Kujala, P.M., Blijenberg, B.G., Stenman, U.-H., Huber, A., Taari, K., Hakama, M., Moss, S.M., de Koning, H.J. and Auvinen, A. for the ERSPC Investigators:
Prostate cancer mortality at 11 years of follow-up. N. Engl. J. Med. 2012; 366: 981-990.
Thulaseedharan, J.V., Malila, N., Hakama, M., Esmy, P.O., Cheriyan, M., Swaminathan, R., Muwonge, R. and Sankaranarayanan, R.: Socio demographic and reproductive risk factors for cervical cancer - a large prospective cohort study from rural India. Asian Pacific J. Cancer Prev. 2012; 13: 2991-2995.
Veerus, P., Ficher, K., Hakama, M. and Hemminki, E. for the EPHT Trial.: Results from a blind and a non-blind randomised trial run in parallel: experience from the Estonian Postmenopausal Hormone Therapy (EPHT) Trial. BMC Med. Res. Methodol. 2012; 12: 44.
Wu, G.H.-M., Auvinen, A., Määttänen, L., Tammela, T.L.J., Stenman, U.-H., Hakama, M., Yen, A.M.-F. and Chen, H.-H.: Number of screens for overdetection as an indicator of absolute risk of overdiagnosis in prostate cancer screening. Int. J. Cancer 2012; 131: 1367-1375.
Wu, G.H.-M., Auvinen, A., Yen, A.M.-F., Hakama, M., Tammela, T.L., Stenman, U.-H., Kujala, P., Ruutu, M. and Chen, H.-H.: The impact of interscreening interval and age on prostate cancer screening with prostate-specific antigen. Eur. Urol. 2012; 61: 1011-1018.
Wu, G.H.-M., Auvinen, A., Yen, A.M.-F., Hakama, M., Walter, S.D. and Chen, H.-H.: A stochastic model for survival of early prostate cancer with adjustments for leadtime, length bias and over-detection. Biometrical J. 2012; 54: 20-44.
Anttila, A., Pokhrel, A., Kotaniemi-Talonen, L., Hakama, M., Malila, N. and Nieminen, P.: Cervical cancer patterns with automation-assisted and conventional cytological screening: a randomized study. Int. J. Cancer 2011; 128: 1204-1212.
Chiu, S.Y.-H., Malila, N., Yen, A.M.-F., Anttila, A., Hakama, M. and Chen, T.H.-H.: Analytical decision model for sample size and effectiveness projections for use in planning a population-based randomized controlled trial of colorectal cancer screening. J. Eval. Clin. Pract. 2011; 17: 123-129.
El-Amin, S.E., Nwaru, B.I., Ginawi, I., Pisani, P. and Hakama, M.: The role of parents, friends and teachers in adolescents' cigarette smoking and tombak dipping in Sudan. Tob. Control 2011; 20: 94-99.
Ganesh, B., Swaminathan, R., Mathew, A., Sankaranarayanan, R. and Hakama, M.: Loss-adjusted hospital and population-based survival of cancer patients. In: Cancer Survival in Africa, Asia, the Caribbean and Central America. Eds. R. Sankaranarayanan and R. Swaminathan. IARC Scient. Publ. No. 162. IARC, Lyon 2011, 99. 15-21.
Kotaniemi-Talonen, L., Malila, N., Anttila, A., Nieminen, P. and Hakama, M.: Intensified screening among high-risk women within the organised screening programme for cervical cancer in Finland. Acta Oncol. 2011; 50: 106-111.
Malila, N., Palva, T., Malminiemi, O., Paimela, H., Anttila, A., Hakulinen, T., Järvinen, H., Kotisaari, M.-L., Pikkarainen, P., Rautalahti, M., Sankila, R., Vertio, H. and Hakama, M.: Coverage and performance of colorectal cancer screening with the faecal occult blood test in Finland. J. Med. Screen. 2011; 18: 18-23.
Malila, N., Palva, T., Malminiemi, O., Paimela, H., Anttila, A., Hakulinen, T., Järvinen, H., Kotisaari, M.-L., Pikkarainen, P., Rautalahti, M., Sankila, R., Vertio, H. and Hakama, M.: Colorectal cancer screening, ethics and evidence-based public policy. Response to Dr. Braillon. J. Med. Screen. 2011; 18: 103-104.
Parvinen, I., Chiu, S., Pylkkänen, L., Klemi, P., Immonen-Räihä, P., Kauhava, L., Malila, N. and Hakama, M.: Effects of annual vs triennial mammography interval on breast cancer incidence and mortality in ages 40-49 in Finland. Brit. J. Cancer 2011, 105; 1388-1391.
Anttila, A., Kotaniemi-Talonen, L., Leinonen, M., Hakama, M., Laurila, P., Tarkkanen, J., Malila, N. and Nieminen, P.: Rate of cervical cancer, severe intraepithelial neoplasia, and adenocarcinoma in situ in primary HPV DNA screening with cytology triage: randomised study within organised screening programme. Brit. Med. J. 2010; 340:c1804, doi:1136/bmj.c1804.
Finne, P., Fallah, M., Hakama, M., Ciatto, S., Hugosson, J., de Koning, H., Moss, S., Nelen. V. and Auvinen, A.: Lead-time in the European Randomised Study of Screening for Prostate Cancer. Eur. J. Cancer 2010; 46: 3102-3108.
Hansson, M.G. and Hakama, M.: Ulysses contracts for the doctor and for the patient. Contemp. Clin. Trials 2010; 31: 202-206.
Pukkala, E., Malila, N. and Hakama, M.: Socioeconomic differences in incidence of cervical cancer in Finland by cell type. Acta Oncol. 2010, 49: 180-184.
Sumelahti, M.-L., Hakama, M., Elovaara, I. and Pukkala, E.: Causes of death among patients with multiple sclerosis. Mult. Scler. 2010; 16: 1437-1442.
Wu, J.C.-Y., Anttila, A., Yen, A.M.-F., Hakama, M., Saarenmaa, I., Sarkeala, T., Malila, N., Auvinen, A., Chiu, S.Y.-H. and Chen, T.H.-H.: Evaluation of breast cancer service screening programme with a Bayesian approach: mortality analysis in a Finnish region. Breast Cancer Res. Treat. 2010; 121: 671-678.
Wu, J.C.-Y., Hakama, M., Anttila, A., Yen, A.M.-F., Malila, N., Sarkeala, T., Auvinen, A., Chiu, S.Y.-H. and Chen,T.H.-H.: Estimation of natural history parameters of breast cancer based on non-randomized organized screening data: subsidiary analysis of effects of inter-screening interval, sensitivity, and attendance rate on reduction of advanced cancer. Breast Cancer Res. Treat. 2010; 122: 553-566.
Auvinen, A., Raitanen, J., Moss, S., de Koning, H.J., Hugosson, J., Tammela, T., Roobol, M., Lilja, H. and Hakama, M.: Test sensitivity in the European prostate cancer screening trial: Results from Finland, Sweden, and the Netherlands. Cancer Epidemiol. Biomerkers Prev. 2009; 18: 2000-2005.
Holli, K., Hietanen, P., Saaristo, R., Huhtala, H., Hakama, M. and Joensuu, H.: Radiotherapy after segmental resection of breast cancer with favorable prognostic features: 12-year follow-up results of a randomized trial. J. Clin. Oncol. 2009; 27: 927-932.
Roobol, M.J., Kerkhof, M., Schröder, F.H., Cuzick, J., Sasieni, P., Hakama, M., Stenman, U.H., Ciatto, S., Nelen, V., Kwiatkowski, M., Lujan, M., Lilja, H., Zappa, M., Denis, L., Recker, R., Berenguer, A., Ruutu, M., Kujala, P., Bangma, C.H., Aus, G., Tammela, T.L.J., Villers, A., Rebillard, X., Moss, S.M., de Koning, H.J., Hugosson, J. and Auvinen, A.:
Prostate cancer mortality reduction by prostate-specific antigen-based screening adjusted for nonattendance and contamination in the European Randomised Study of Screening for Prostate Cancer (ERSPC). Eur. Urol. 2009; 56: 584-591.
Simen-Kapeu, A., Luostarinen, T., Jellum, E., Dillner, J., Hakama, M., Koskela, P., Lenner, P., Löve, A., Mahlamäki, E., Thoresen, S., Tryggvadóttir, L., Wadell, G., Youngman, L. and Lehtinen, M.: Is smoking an independent risk factor for invasive cervical cancer? A nested case-control study within Nordic biobanks. Am. J. Epidemiol. 2009; 169: 480-488.
Anttila, A., Ronco, G., Lynge, E., Fender, M., Arbyn, M., Baldauf, J.-J., Patnick, J., McGoogan, E., Hakama, M. and Miller, A.B.: Epidemiological guidelines for quality assurance in cervical screening. In: European guidelines for quality assurance in cervical cancer screening. Eds. M. Arbyn, A. Anttila, J. Jordan, G. Ronco, U. Schenck, N. Segnan, H.G. Wiener, A. Herbert, J. Daniel, L. von Karsa. European Commission. European Communities, Brussels 2008, pp. 11-68.
Finne, P., Auvinen, A., Määttänen, L., Tammela, T.L., Ruutu, M., Juusela, H., Martikainen, P., Hakama, M. and Stenman, U.-H.: Diagnostic value of free prostate-specific antigen among men with a prostate-specific antigen level of <3.0mug per liter. Eur. Urol. 2008; 54: 362-370.
Gouveia, J., Coleman, M.P., Haward, R., Zanetti, R., Hakama, M., Borras, J.M., Primic-Zakelj, M., de Koning, H.J. and Travado, L.: Improving cancer control in the European Union: Conclusions from the Lisbon round-table under the Portuguese EU Presidency, 2007. Eur. J. Cancer 2008; 44: 1457-1462.
Hakama, M. and Auvinen, A.: Cancer screening. In: International Encyclopedia of Public Health. Eds. K. Heggenhougen and S. Quah. San Diego, Academic Press 2008; pp. 464-480.
Hakama, M., Coleman, M.P., Alexe, D.-M. and Auvinen, A.: Cancer screening. In: Responding to the challenge of cancer in Europe. Eds. M.P. Coleman, D.-M. Alexe, T. Albreht and M. McKee, Institute of Public Health of the Republic of Slovenia. Ljubljana 2008, pp. 69-92 (http://www.euro.who.int/Document/E91137.pdf).
Hakama, M., Coleman, M.P., Alexe, D.-M. and Auvinen, A.: Cancer screening: Evidence and practice in Europe 2008. Eur. J. Cancer 2008; 44: 1404-1413.
Hakama, M. and Malila, N.: Millainen on hyvä seulonta? Duodecim 2008; 124: 2193-2199. (in Finnish)
Kotaniemi-Talonen, L., Anttila, A., Malila, N., Tarkkanen, J., Laurila, P., Hakama, M. and Nieminen, P.: Screening with a primary human papillomavirus test does not increase detection of cervical cancer and intraepithelial neoplasia 3. Eur. J. Cancer 2008; 44: 565-571.
Kotaniemi-Talonen, L., Malila, N., Nieminen, P., Anttila, A., Tarkkanen, J., Laurila, P. and Hakama, M.: Test positivity cutoff level of a high risk human papillomavirus test could be increased in routine cervical cancer screening. Int. J. Cancer 2008; 123: 2902-2906.
Läärä, E., Luostarinen, T., Hakulinen, T., Lyytikäinen, O., Sarna, O., Virtala, A.-M., Riihimäki, H. and Hakama, M.(Ed.).: The English-Finnish-English Vocabulary in Epidemiology. Suomen Epidemiologian Seura ja Duodecim 2008 Helsinki (in Finnish). http://www.finepi.org/files/englantisuomi.pdf, http://www.finepi.org/files/suomienglanti.pdf.
Malila, N., Oivanen, T. and Hakama, M.: Implementation of colorectal cancer screening in Finland: Experiences from the first three years of a public health programme. Z. Gastroenterol. 2008; 46: Suppl. 1: S25-S28.
Malila, N., Oivanen, T., Malminiemi, O. and Hakama, M.: Test, episode, and programme sensitivities of screening for colorectal cancer as a public health policy in Finland: experimental design. Brit. Med. J. 2008; 337: 1341-1344.
Cardis, E., Vrijheid, M., Blettner, M., Gilbert, E., Hakama, M., Hill, C., Howe, G., Kaldor, J., Muirhead, C.R., Schubauer-Berigan, M., Yoshimura, T., Bermann, F., Cowper, G., Fix, J., Hacker, C., Heinmiller, B., Marshall, M., Thierry-Chef, I., Utterback, D., Ahn, Y.O., Amoros, E., Ashmore, P., Auvinen, A., Bae, J.-M., Bernar, J., Biau, A., Combalot, E., Deboodt, P., Diez Sacristan, A., Eklöf, M., Engels, H., Engholm, G., Gulis, G., Habib, R.R., Holan, K., Hyvönen, H., Kerekes, A., Kurtinaitis, J., Malker, H., Martuzzi, M., Mastauskas, A., Monnet, A., Moser, M., Pearce, M.S., Richardson, D.B., Rodriguez-Artalejo, F., Rogel, A., Tardy, H., Telle-Lamberton, M., Turai, I., Usel, M. and Veress, K.:
The 15-country collaborative study of cancer risk among radiation workers in the nuclear industry: Estimates of radiation-related cancer risks. Radiat. Res. 2007; 167: 396-416.
Hakama, M.: Pahanlaatuisten kasvainten seulonta väestöstä. Duodecim 2007; 123: 157-158. (in Finnish)
Hakama, M.: Syöpäseulonnat. In: Syöpätaudit. Eds. H. Joensuu, P. Roberts, L. Teppo and M. Tenhunen. Kustannus Oy Duodecim, Helsinki 2007, pp. 50-58. (in Finnish)
Hakama, M., Auvinen, A., Day, N.E. and Miller, A.B.: Sensitivity in cancer screening. J. Med. Screen. 2007; 14: 174-177.
Kotaniemi-Talonen, L., Nieminen, P., Hakama, M., Seppänen, J., Ikkala, J., Martikainen, J., Tarkkanen, J., Toivonen, T. and Anttila, A.: Significant variation in performance does not reflect the effectiveness of the cervical cancer screening programme in Finland. Eur. J. Cancer 2007; 43: 169-174.
Malila, N., Hakama, M. and Pukkala, E.: A 25-year follow-up of a population screened with faecal occult blood test in Finland. Acta Oncol. 2007; 46: 1103-1106.
Murtola, T.J., Tammela, T.L.J., Määttänen, L., Hakama, M. and Auvinen, A.: Prostate cancer risk among users of finasteride and alpha-blockers - A population based case-control study. Eur. J. Cancer 2007; 43: 775-781.
Määttänen, L., Hakama, M., Tammela, T.L.J., Ruutu, M., Ala-Opas, M., Juusela, H., Martikainen, P., Stenman, U.-H. and Auvinen, A.: Specificity of serum prostate-specific antigen determination in the Finnish prostate cancer screening trial. Br. J. Cancer 2007; 96: 56-60.
Nieminen, P., Kotaniemi-Talonen, L., Hakama, M., Tarkkanen, J., Martikainen, J., Toivonen, T., Ikkala, J. and Anttila, A.: Randomized evaluation trial on automation-assisted screening for cervical cancer: Results after 777,000 invitations. J. Med. Screen. 2007; 14: 23-28.
Tuohimaa, P., Tenkanen, L., Syvälä, H., Lumme, S., Hakulinen, T., Dillner, J. and Hakama, M.: Interaction of factors related to the metabolic syndrome and vitamin D on risk of prostate cancer. Cancer Epidemiol. Biomarkers Prev. 2007; 16: 302-307.
Vrijheid, M., Cardis, E., Blettner, M., Gilbert, E., Hakama, M., Hill, C., Howe, G., Kaldor, J., Muirhead, C.R., Schubauer-Berigan, M., Yoshimura, T., Ahn, Y.O., Ashmore, P., Auvinen, A., Bae, J.-M., Engels, H., Gulis, G., Habib, R.R., Hosoda, Y., Kurtinaitis, J., Malker, H., Moser, M., Rodriguez-Artalejo, F., Rogel, A., Tardy, H., Telle-Lamberton, M., Turai, I., Usel, M. and Veress, K.:
The 15-country collaborative study of cancer risk among radiation workers in the nuclear industry: Design, epidemiological methods and descriptive results. Radiat. Res. 2007; 167: 361-379.
Anttila, A., Hakama, M., Kotaniemi-Talonen, L. and Nieminen, P.: Alternative technologies in cervical cancer screening: a randomised evaluation trial. BMC Public Health 2006; 6: 252 (doi:10.1186/1471-2458-6-252).
Darby, S., Hill, D., Deo, H., Auvinen, A., Barros-Dios, J.M., Baysson, H., Bochicchio, F., Falk, R., Farchi, S., Figueiras, A., Hakama, M., Heid, I., Hunter, N., Kreienbrock, L., Kreuzer, M., Lagarde, F.C., Mäkeläinen, I., Muirhead, C., Oberaigner, W., Pershagen, G., Ruosteenoja, E., Schaffrath Rosario, A., Tirmarche, M., Tomasek, L., Whitley, E., Wichmann, H.-E. and Doll, R.:
Residential radon and lung cancer - detailed results of a collaborative analysis of individual data on 7148 persons with lung cancer and 14 208 persons without lung cancer from 13 epidemiologic studies in Europe. Scand. J. Work Environ. Health 2006; 32: Suppl. 1: 1-84.
Davies, P., Arbyn, M., Dillner, J., Kitchener, H.C., Meijer, C.J.L.M., Ronco, G. and Hakama, M.: A report on the current status of European research on the use of human papillomavirus testing for primary cervical cancer screening. Int. J. Cancer 2006; 118: 791-796.
Hakama, M.: Family history in colorectal cancer surveillance strategies. Lancet 2006; 368: 101-103.
Hakama, M. and Bray, F.: Kohdunkaulasyövän torjunta Suomessa. Maailman huipulta pohjalle. Duodecim 2006; 122: 2425-2428. (in Finnish)
Hakama, M., Hakulinen, T., Johansson, R. , Rautalahti, M. and Vertio, H. (Eds): Syöpä 2015. Suomen Syöpäyhdistyksen julkaisuja nro 68. Syöpäsäätiö. Helsinki 2006. (in Finnish)
Hakama, M., Hoff, G., Kronborg, O. and Påhlman, L.: In response ("Population screening for colorectal cancer - how strong is the evidence"). Acta Oncol. 2006; 45: 214-215.
Kotaniemi-Talonen, L., Malila, N., Anttila, A. and Hakama, M.: Papa-seulonta edelleen avainasemassa kohdunkaulan syövän ehkäisyssä. Suom. Lääk.-L. 2006; 61: 4068-4069. (in Finnish)
Poppius, E., Virkkunen, H., Hakama, M. and Tenkanen, L.: The sense of coherence and incidence of cancer - role of follow-up time and age at baseline. J. Psychosom. Res. 2006; 61: 205-211.
Sarkeala, T., Hakama, M., Saarenmaa, I., Hakulinen, T., Forsman, H. and Anttila, A.: Episode sensitivity in association with process indicators in the Finnish breast cancer screening program. Int. J. Cancer 2006; 118: 174-179.
Törnberg, S., Kemetli, L., Lynge, E., Olsen, A.H., Hofvind, S., Wang, H., Anttila, A., Hakama, M. and Nyström, L.: Breast cancer incidence and mortality in the Nordic capitals, 1970-1998. Trends related to mammography screening programmes. Acta Oncol. 2006; 45: 528-535.
Anttila, A., Nieminen, P. and Hakama, M.: Cervical cytology as a screening test. In: The health professional's HPV Handbook 3: HPV and cervical cancer: public health perspectives. Eds. W. Prendiville and P. Davies. Taylor & Francis, London 2005, pp. 11-23.
Anttila, T., Tenkanen, L., Lumme, S., Leinonen, M., Gislefoss, R.E., Hallmans, G., Thoresen, S., Hakulinen, T., Luostarinen, T., Stattin, P., Saikku, P., Dillner, J., Lehtinen, M. and Hakama, M.: Chlamydial antibodies and risk of prostate cancer. Cancer Epidemiol. Biomarkers Prev. 2005; 14: 385-389.
Bray, F., Carstensen, B., Möller, H., Zappa, M., Zakelj, M.P., Lawrence, G., Hakama, M. and Weiderpass, E.: Incidence trends of adenocarcinoma of the cervix in 13 European countries. Cancer Epidemiol. Biomarkers Prev. 2005; 14: 2191-2199.
Bray, F., Loos, A.H., McCarron, P., Weiderpass, E., Arbyn, M., Möller, H., Hakama, M. and Parkin, D.M.: Trends in cervical squamous cell carcinoma incidence in 13 European countries: Changing risk and the effects of screening. Cancer Epidemiol. Biomarkers Prev. 2005; 14: 677-686.
Cardis, E., Vrijheid, M., Blettner, M., Gilbert, E., Hakama, M., Hill, C., Howe, G., Kaldor, J., Muirhead, C.R., Schubauer-Berigan, M., Yoshimura, T., Bermann, T., Cowper, G., Fix, J., Hacker, C., Heinmiller, B., Marshall, M., Thierry-Chef, I., Utterback, D., Ahn, Y.-O., Amoros, E., Ashmore, P., Auvinen, A., Bae, J.-M., Bernar Solano, J., Biau, A., Combalot, E., Deboodt, P., Diez Sacristan, A., Eklof, M., Engels, H., Engholm, G., Gulis, G., Habib, R., Holan, K., Hyvönen, H., Kerekes, A., Kurtinaitis, J., Malker, H., Martuzzi, M., Mastauskas, A., Monnet, A., Moser, M., Pearce, M.S., Richradson, D.B., Rodriguez-Artalejo, F., Rogel, A., Tardy, H., Telle-Lamberton, M., Turai, I., Usel, M. and Veress, K.:
Risk of cancer after low doses of ionising radiation: retrospective cohort study in 15 countries. BMJ. 2005: 331: 77 - 80. (Longer version in electronic form was published 29 June 2005: http://bmj.com/cgi/doi/10.1136/bmj.38499.599861.E0)
Darby, S., Hill, D., Auvinen, A., Barros-Dios, J.M., Baysson, H., Bochicchio, F., Deo, H., Falk, R., Forastiere, F., Hakama, M., Heid, I., Kreienbrock, L., Kreuzer, M., Lagarde, F., Mäkeläinen, I., Muirhead, C., Oberaigner, W., Pershagen, G., Ruano-Ravina, A., Ruosteenoja, E., Schaffrath Rosario, A., Tirmarche, M., Tomásek, L., Whitley, E., Wichmann, H.E. and Doll, R.:
Radon in homes and risk of lung cancer: collaborative analysis of individual data from 13 European case-control studies. BMJ 2005; 330: 223-226. (Longer version in electronic form was published 21 December 2004: http://bmj.com/cgi/doi/10.1136/bmj.38308.477650.63.)
Hakama, M.: Ikuinen elämä - biologiaa vai teologiaa. Jäähyväisluento 17.5.2005. Sosiaalilääketiet. Aik.-L. 2005; 42: 353-355. (in Finnish)
Hakama, M.: Rintasyövän seulonnan vaikuttavuus. Suom. Lääk.-L. 2005; 60: 2315-2316. (in Finnish)
Hakama, M. and Hakulinen, T.: Effect of sample pooling in the blood biochemistry and the risk of stomach cancer. Proceedings of the 6th International Gastric Congress, Yokohama, Japan, May 4-7, 2005. Edited by M. Kitajima and Y. Otani. Medimond, Bologna 2005; 21-23.
Hakama, M., Hoff, G. , Kronborg, O. and Påhlman, L.: An Acta Oncologica Expert Report. Screening for colorectal cancer. Acta Oncol. 2005; 44: 425-439.
Järvenpää, R., Holli, K. and Hakama, M.: Resource savings in the single reading of plain radiographs by oncologist only in cancer patient follow-up: A randomised study. Acta Oncol. 2005; 44: 149-154 (Published also in Turkish).
Kokko, R., Hakama, M. and Holli, K.: Follow-up cost of breast cancer patients with localized disease after primary treatment: a randomized trial. Breast Cancer Res. Treat. 2005; 93: 255-260.
Korodi, Z., Dillner, J., Jellum, E., Lumme, S., Hallmans, G., Thoresen, S., Hakulinen, T., Stattin, P., Luostarinen, T., Lehtinen, M. and Hakama, M.: Human papillomavirus 16, 18 and 33 infections and risk of prostate cancer: A Nordic nested case-control study. Cancer Epidemiol. Biomarkers Prev. 2005; 14: 2952-2955.
Kotaniemi-Talonen, L., Nieminen, P., Anttila, A. and Hakama, M.: Routine cervical screening with primary HPV testing and cytology triage protocol in a randomised setting. Br. J. Cancer 2005; 93: 862-867.
Malila, N., Anttila, A. and Hakama, M.: Colorectal cancer screening in Finland: details of the national screening programme implemented in Autumn 2004. J. Med. Screen. 2005; 12: 28-32.
Nieminen, P., Kotaniemi, L., Hakama, M., Tarkkanen, J., Martikainen, J., Toivonen, T., Ikkala, J., Luostarinen, T. and Anttila, A.: A randomised public-health trial on automation-assisted screening for cervical cancer in Finland: Performance with 470,000 invitations. Int. J. Cancer 2005; 115: 307-311.
Sarkeala, T., Anttila, A., Saarenmaa, I. and Hakama, M.: Validity of process indicators of screening for breast cancer to predict mortality reduction. J. Med. Screen. 2005; 12: 33-37.
Anttila, A., Ronco, G., Clifford, G., Bray, F., Hakama, M., Arbyn, M. and Weiderpass, E.: Cervical cancer screening programmes and policies in 18 European countries. Br. J. Cancer 2004; 91: 935-941.
Auvinen, A., Hakama, M., Ala-Opas, M., Vornanen, T., Leppilahti, M., Salminen, P. and Tammela, T.L.: A randomized trial of choice of treatment in prostate cancer: the effect of intervention on the treatment chosen. BJU Int. 2004; 93: 52-56.
Auvinen, A., Määttänen, L., Finne, P., Stenman, U.H., Aro, J., Juusela, H., Rannikko, S., Tammela, T.L. and Hakama, M.: Test sensitivity of prostate-specific antigen in the Finnish randomised prostate cancer screening trial. Int. J. Cancer 2004; 111: 940-943.
Finne, P., Finne, R., Bangma, C., Hugoson, J., Hakama, M., Auvinen, A. and Stenman, U.H.: Algorithms based on prostate-specific antigen (PSA), free PSA, digital rectal examination and prostate volume reduce false-positive PSA results in prostate cancer screening. Int. J. Cancer 2004; 111: 310-315.
Hakama, M.: Kohdunkaulan syövän seulonta ja sen vaikutus. Focus. Oncol. 2004; No. 5: 14-16. (in Finnish)
Hakama, M., Hakulinen, T., Kenward, M.G., Aaran, R.-K., Aromaa, A., Knekt, P., Nikkari, T., Teppo, L. and Peto, R.: Blood biochemistry and the risk of cancer. Acta Oncol. 2004; 43: 667-674.
Hakama, M., Luostarinen, T. and Hakulinen, T.: Survival of in situ carcinoma of cervix uteri: A 50-year follow-up in Finland. Int. J. Cancer 2004; 112: 1072-1074.
Järvenpää, P., Holli, K. and Hakama, M.: Double-reading of plain radiographs - no benefit with regard to earliness of diagnosis of cancer recurrence: a randomised follow-up study. Eur. J. Cancer 2004; 40: 1668-1673.
Loos, A.H., Bray, F., McCarron, P., Weiderpass, E., Hakama, M. and Parkin, D.M.: Sheep and goats: separating cervix and corpus uteri from imprecisely coded uterine cancer deaths, for studies of geographical and temporal variations in mortality. Eur. J. Cancer 2004; 40: 2794-2803.
Luostarinen, T., Lehtinen, M., Bjorge, T., Abeler, V., Hakama, M., Hallmans, G., Jellum, E., Koskela, P., Lenner, P., Lie, A.K., Paavonen, J., Pukkala, E., Saikku, P., Sigstad, E., Thoresen, S., Youngman, L.D., Dillner, J. and Hakulinen, T.: Joint effects of different human papillomaviruses and Chlamydia trachomatis infections on risk of squamous cell carcinoma of the cervix uteri. Eur. J. Cancer 2004; 40: 1058 - 1065.
Myles, J.P., Salminen, T., Duffy, S.W., Prevost, T.C., Day, N.E. and Hakama, M.: Prospective estimation of rates of change in mammographic parenchymal patterns: influence of age and of hormone replacement therapy. Breast 2004; 13: 56-60.
Mäkinen, T., Tammela, T.L.J., Stenman, U.-H., Määttänen, L., Aro, J., Juusela, H., Martikainen, P., Hakama, M. and Auvinen, A.: Second round results of the Finnish population-based prostate cancer screening trial. Clin. Cancer Res. 2004; 10: 2231-2236.
Nieminen, P., Vuorma, S., Viikki, M., Hakama, M. and Anttila, A.: Comparison of HPV test versus conventional and automation-assisted Pap screening as potential screening tools for preventing cervical cancer. Br. J. Obstet. Gynaecol. 2004; 111: 842-848.
Sarkeala, T., Anttila, A., Forsman, H., Luostarinen, T., Saarenmaa, I. and Hakama, M.: Process indicators from ten centres in the Finnish breast cancer screening programme from 1991 to 2000. Eur. J. Cancer 2004; 40: 2116-2125.
Sriamporn, S., Swaminathan, R., Parkin, D.M., Kamsa-ard, S. and Hakama, M.: Loss-adjusted survival of cervix cancer in Khon-Kaen, Northeast Thailand. Br. J. Cancer 2004; 91: 106-110.
Stattin, P., Lumme, S., Tenkanen, L., Alfthan, H., Jellum, E., Hallmans, G., Thoresen, S., Hakulinen, T., Luostarinen, T., Lehtinen, M., Dillner, J., Stenman, U.-H. and Hakama, M.: High levels of circulating testosterone are not associated with increased prostate cancer risk: a pooled prospective study. Int. J. Cancer 2004; 108: 418-424.
Sumelahti, M.L., Pukkala, E. and Hakama, M.: Cancer incidence in multiple sclerosis: a 35-year follow-up. Neuroepidemiology 2004; 23: 224-227.
Tuohimaa, P., Tenkanen, L., Ahonen, M., Lumme, S., Jellum, E., Hallmans, G., Stattin, P., Harvei, S., Hakulinen, T., Luostarinen, T., Dillner, J., Lehtinen, M. and Hakama, M.: Both high and low levels of blood vitamin D are associated with a higher prostate cancer risk: a longitudinal, nested case-control study in the Nordic countries. Int. J. Cancer 2004; 108: 104-108.
Tuohimaa, P., Tenkanen, L., Ahonen, M., Lumme, S., Jellum, E., Hallmans, G., Stattin, P., Harvei, S., Hakulinen, T., Luostarinen, T., Dillner, J., Lehtinen, M. and Hakama, M.: Metabolism of 25-hydroxyvitamin D, may explain the U-shaped risk curve for prostate cancer. Int. J. Cancer 2004; 111: 469.
Finne, P., Stenman, U.-H., Määttänen, L., Mäkinen, T., Tammela, T.L.J., Martikainen, P., Ruutu, M., Ala-Opas, M., Aro, J., Karhunen, P.J., Lahtela, J., Rissanen, P., Juusela, H., Hakama, M. and Auvinen, A.: The The Finnish trial of prostate cancer screening: where are we now? BJU Int. 2003; 92: Suppl. 2: 22-26.
Hakama, M.: Suolistosyövän seulonta - tausta ja periaatteet. Focus Oncol. 2003; No. 4: 40-41. (in Finnish)
Hakama, M. and Auvinen, A.: Reliability and validity of prostate-specific antigen. JAMA 2003; 290: 1705 (author´s reply: 1705 -1706).
Kokko, R., Hakama, M. and Holli, K.: Role of chest x-ray in diagnosis of the first breast cancer relapse: a randomized trial. Scand. J. Work Environ. Health 2003; 29: 64-70.
Lehtinen, M., Pawlita, M., Zumbach, K., Lie, K., Hakama, M., Jellum, E., Koskela, P., Luostarinen, T., Paavonen, J., Pukkala, E., Sigstad, E., Thoresen, S. and Dillner, J.: Evaluation of antibody response to human papillomavirus early proteins in women in whom cervical cancer developed 1 to 20 years later. Am. J. Obstet. Gynecol. 2003; 188: 49-55.
Malila, N., Anttila, A., Elovainio, L., Hakulinen, T., Järvinen, H., Paimela, H., Pikkarainen, P., Rautalahti, M. and Hakama, M.: Suolistosyövän seulonta ja sen vaikuttavuuden arviointi Suomessa. Duodecim 2003; 119: 1115-1123. (in Finnish)
Mäkinen, T., Tammela, T.L., Hakama, M., Stenman, U.-H., Rannikko, S., Aro, J., Juusela, H., Määttänen, L. and Auvinen, A.: Tumor characteristics in a population-based prostate cancer screening trial with prostate-specific antigen. Clin. Cancer Res. 2003; 9: 2435-2439.
Nieminen, P., Hakama, M., Viikki, M., Tarkkanen, J. and Anttila, A.: Prospective and randomised public-health trial on neural network-assisted screening for cervical cancer in Finland: results on the first year. Int. J. Cancer 2003; 103: 422-426.
Stattin, P. and Hakama, M.: Correspondence re: B.-L. Adam et al., Serum protein fingerprinting coupled with a pattern-matching algorithm distinguishes prostate cancer from benign hyperplasia and healthy men. Cancer Res. 2002: 62: 3609-3614. Cancer Res. 2003; 63: 2701.
Tadjalli-Mehr, K., Becker, N., Rahu, M., Stengrevics, A., Kurtinaitis, J. and Hakama, M.: Randomized trial with fruits and vegetables in prevention of cancer. Acta Oncol. 2003; 42: 287-293.
Auvinen, A., Määttänen, L., Stenman, U.-H., Tammela, T., Rannikko, S., Aro, J., Juusela, H. and Hakama, M.: Lead-time in prostate cancer screening (Finland). Cancer Causes Control 2002; 13: 279-285.
Auvinen, A., Pukkala, E., Hyvönen, H., Hakama, M. and Rytömaa, T.: Cancer incidence among Finnish nuclear reactor workers. J. Occup. Environ. Med. 2002; 44: 634-638.
Finne, P., Auvinen, A., Aro, J., Juusela, H., Määttänen, L., Rannikko, S., Hakama, M., Tammela, T. and Stenman, U.-H.: Who should be biopsied in prostate cancer screening? Estimation of prostate cancer risk on the basis of total and free prostate-specific antigen, prostate volume and digital rectal examination. Eur. Urol. 2002; 41: 619-627.
Hakama, M.: Cancer screening for medical oncologists: definitions and aims. Ann. Oncol. 2002; 13 (suppl. 4): 185-188.
Hakama, M.: Screening for lung cancer. J. Clin. Oncol. 2002; 20: 3931.
Hakulinen, T., Hakama, M., Sankila, R., Pukkala, E. and Söderman, B.: Finland. In: Cancer Incidence in Five Continents Vol. VIII. Eds. D.M. Parkin, S.L. Whelan, J. Ferlay, L. Teppo and D.B. Thomas. IARC Scientific Publications No. 155. International Agency for Research on Cancer. Lyon 2002, pp. 328-329.
Kokko, R., Holli, K. and Hakama, M.: Ca 15-3 in the follow-up of localized breast cancer: a prospective study. Eur. J. Cancer 2002; 38: 1189-1193.
Lehtinen, M., Koskela, P., Jellum, E., Bloigu, A., Anttila, T., Hallmans, G., Luukkaala, T., Thoresen, S., Youngman, L., Dillner, J. and Hakama, M.: Herpes simplex virus and risk of cervical cancer: a longitudial, nested case-control study in the Nordic countries. Am. J. Epidemiol. 2002; 156: 687-692.
Myles, J.P., Duffy, S.W., Prevost, T.C., Day, N.E., Hakama, M. and Salminen, T.: Markov chain Monte Carlo inference applied to a complex model for the longitudinal analysis of breast cancer. Appl. Stat. 2002; 51: 197-207.
Mäkinen, T., Auvinen, A., Hakama, M., Stenman, U.-H. and Tammela, T.L.J.: Acceptability and complications of prostate biopsy in population-based PSA screening versus routine clinical practice: a prospective, controlled study. Urology 2002; 60: 846-850.
Mäkinen, T., Tammela, T.L.J., Stenman, U.-H., Määttänen, L., Rannikko, S., Aro, J., Juusela, H., Hakama, M. and Auvinen, A.: Family history and prostate cancer screening with prostate-specific antigen. J. Clin. Oncol. 2002; 20: 2658-2663.
Nieminen, P., Hakama, M., Tarkkanen, J. and Anttila, A.: Effect of type of screening laboratory on population-based occurrence cervical lesions in Finland. Int. J. Cancer 2002; 99: 732-736.
Stattin, P., Adlercreutz, H., Tenkanen, L., Jellum, E., Lumme, S., Hallmans, G., Harvei, S., Teppo, L., Stumpf, K., Luostarinen, T., Lehtinen, M., Dillner, J. and Hakama, M.: Circulating enterolactone and prostate cancer risk: a Nordic nested case-control study. Int. J. Cancer 2002; 99: 124-129.
de Koning, H., Auvinen, A., Berenguer Sanchez, A., Calais da Silva, F., Ciatto, S., Denis, L., Gohagan, J.K., Hakama, M., Hugosson, J., Kranse, R., Nelen, V., Prorok, P.C. and Schröder, F.H.: Large-scale randomized prostate cancer screening trials: program performances in the European randomized screening for prostate cance trial and the prostate, lung, colorectal and ovary cancer trial. Int. J. Cancer 2002; 97: 237-244.
Auvinen, A., Vornanen, T., Tammela, T.L.J., Ala-Opas, M., Leppilahti, M., Salminen, P. and Hakama, M.: A randomized trial of the choice of treatment in prostate cancer: design and baseline characteristics. BJU Int. 2001; 88: 708-715.
Hakama, M.: Planning and designing of screening programmes. In: Evaluation and Monitoring of Screening Programmes. Eds. R. Sankila, E. Démaret, M. Hakama, E. Lynge, L.J. Schouten, D.M. Parkin. European Commission, Europe Against Cancer Programme. Brussels 2001; pp. 13-28.
Hakama, M. and Riihimäki, H.: Suomen Akatemia ja kansanterveystutkimus. Sosiaalilääketiet. Aik.-L. 2001; 38: 205-207. (in Finnish)
Hakama, M., Stenman, U.-H., Aromaa, A., Leinonen, J., Hakulinen, T. and Knekt, P.: Validity of the prostate specific antigen test for prostate cancer screening: followup study with a bank of 21,000 sera in Finland. J. Urol. 2001; 166: 2189-2192.
Holli, K., Saaristo, R., Isola, J., Joensuu, H. and Hakama, M.: Lumpectomy with or without postoperative radiotherapy for breast cancer with favourable prognostic features: results of a randomized study. Br. J. Cancer 2001; 84: 164-169.
Isola, J., Auvinen, A., Poutiainen, M., Kakkola, L., Järvinen, T.H.A., Määttänen, L., Stenman, U.-H., Tammela, T., Hakama, M. and Viskorpi, T.: Predictors of biological aggressiveness of prostate specific antigen screening detected prostate cancer. J. Urol. 2001; 165: 1569-1574.
Kallio, M., Nieminen, P., Anttila, A. and Hakama, M.: Organisoidun seulonnan teho verrattuna spontaaniin Papa-kokeeseen invasiivisen kohdunkaulan syövän torjunnassa. Duodecim 2001; 117: 1442-1446. (in Finnish)
Lehtinen, M., Luukkaala, T., Wallin, K.-L., Paavonen, J., Thoresen, S., Dillner, J. and Hakama, M.: Human papillomavirus infection, risk for subsequent development of cervical neoplasia and associated population attributable fraction. J. Clin. Virol. 2001; 22; 117-124.
Mäkinen, T., Tammela, T.L.J., Hakama, M., Stenman, U.-H., Rannikko, S., Aro, J., Juusela, H., Määttänen, L. and Auvinen, A.: Prostate cancer screening within a prostate specific antigen range of 3 to 3.9 ng./ml.: a comparison of digital rectal examination and free prostate specific antigen as supplemental screening tests. J. Urol. 2001; 166: 1339-1342.
Määttänen, L., Auvinen, A., Stenman, U.-H., Tammela, T., Rannikko, S., Aro, J., Juusela, H. and Hakama, M.: Three-year results of the Finnish prostate cancer screening trial. J. Natl. Cancer Inst. 2001; 93: 552-553.
Saarenmaa, I., Salminen, T., Geiger, U., Heikkinen, P., Hyvärinen, S., Isola, J., Kataja, V., Kokko, M.L., Kokko, R., Kumpulainen, E., Kärkkäinen, A., Pakkanen, J., Peltonen, P., Piironen, a., Salo, A., Talviala, M.L. and Hakama, M.: Validity of radiological examinations of patients with breast cancer in different age groups in a population based study. Breast 2001; 10: 78-81.
Saarenmaa, I., Salminen, T., Geiger, U., Heikkinen, P., Hyvärinen, S., Isola, J., Kataja, V., Kokko, M-L., Kokko, R., Kumpulainen, E., Kärkkäinen, A., Pakkanen, J., Peltonen, P., Piironen, A., Salo, A., Talviala, M-L. and Hakama, M.: The visibility of cancer on previous mammograms in retrospective review. Clin. Radiol. 2001; 56: 40-43.
Saarenmaa, I., Salminen, T., Geiger, U., Heikkinen, P., Hyvärinen, S., Isola, J., Kataja, V., Kokko, M.-L., Kokko, R., Kumpulainen, E., Kärkkäinen, A., Pakkanen, J., Peltonen, P., Piironen, A., Salo, A., Talviala, M.-L. and Hakama, M.: The effect of age and density of the breast on the sensitivity of breast cancer diagnostic by mammography and ultrasonography. Breast Cancer Res. Treat. 2001; 67: 117-123.
Sankila, R., Démaret, E., Hakama, M., Lynge, E., Schouten, L. and Parkin, D.M.: Evaluation and Monitoring of Screening Programmes. European Commission, Europe Against Cancer Programme. Brussels 2001.
Ahonen, M.H., Tenkanen, L., Teppo, L., Hakama, M. and Tuohimaa, P.: Prostate cancer risk and prediagnostic serum 25-hydroxyvitamin D levels (Finland). Cancer Causes Control 2000; 11: 847-852.
Anttila, A., Nieminen, P. and Hakama, M.: Recent increase in cervical cancer incidence in Finland: Implications for prevention. In: 4th International Multidisciplinary congress EUROGIN 2000, Paris, France April 5-9, 2000. Ed. J. Monsonego. Monduzzi Editore, Bologna 2000, pp 245-249.
Davis, P., Hakama, M., Hisamichi, S., Kakizoe, T., Sano, T. and Sugimura, T.: Report of the Thirteenth International Symposium of the Foundation for Promotion of Cancer Research: Cancer screening - past, present and future. Jpn J. Clin. Oncol. 2000; 30: 322-331.
Finne, P., Auvinen, A., Koistinen, H., Zhang, W-M., Määttänen, L., Rannikko, S., Tammela, t., Seppälä, M., Hakama, M. and Stenman, U.-H.: Insulin-like growth factor I not a useful marker of prostate cancer in men with elevated levels of prostate-specific antigen. J. Clin. Endocrinol. Metab. 2000; 85: 2744-2747.
Finne, P., Finne, R., Auvinen, A., Juusela, H., Aro, J., Määttänen, L., Hakama, M., Rannikko, S., Tammela, T.L.J. and Stenman, U.-H.: Predicting the outcome of prostate biopsy in screen-positive men by a multilayer perceptron network. Urology 2000; 56: 418-422.
Hakama, M., Luostarinen, T., Hallmans, G., Jellum, E., Koskela, P., Lehtinen, M., Thoresen, S., Youngman, L. and Hakulinen, T.: Joint effect of HPV16 with chlamydia trachomatis and smoking on risk of cervical cancer: antagonism or misclassification (Nordic countries) Cancer Causes Control 2000; 11: 783-790.
Koskela, P., Anttila, T., Bjorge, T., Brunsvig, A., Dillner, J., Hakama, M., Hakulinen, T., Jellum, E., Lehtinen, M., Lenner, P., Luostarinen, T., Pukkala, E., Saikku, P., Thoresen, S., Youngman, L. and Paavonen, J.: Chlamydia trachomatis infection as a risk factor for invasive cervical cancer. Int. J. Cancer 2000; 85: 35-39.
Nieminen, P., Tarkkanen, J., Timonen, T., Meyer, B., Hakama, M. and Anttila, A.: Kohdunkaulan syövän joukkoseulontalöydösten erot pääkaupunkiseudulla. Duodecim 2000; 116: 2489-2496. (in Finnish)
Saarelma, O. and Hakama, M.: Seulontatutkimusten lupaukset, pettymykset ja mahdollisuudet. Duodecim 2000; 116: 869-870. (in Finnish)
Salminen, T.M., Saarenmaa, I.E., Heikkilä, M.M. and Hakama, M.: Is a dense mammographic parenchymal pattern a contraindication to hormonal replacement therapy? Acta Oncol. 2000; 39: 969-972.
Teppo, L., Anttila, A., Auvinen, A. and Hakama, M.: Syöpätautien seulonta edelleen tarpeellista ja tehokasta. Duodecim 2000; 116: 893-901. (in Finnish)
Viikki, M., Pukkala, E. and Hakama, M.: Risk of cervical cancer subsequent to a positive screening cytology: follow-up study in Finland. Acta Obstet. Gynecol. Scand. 2000; 79: 576-579.
Viikki, M., Pukkala, E., Nieminen, P. and Hakama, M.: Gynaecological infections as risk determinants of subsequent cervical neoplasia. Acta Oncol. 2000; 39: 71-75.
Anttila, A., Pukkala, E:, Söderman, B., Kallio, M., Nieminen, P. and Hakama, M.: Effect of organized screening on cervical cancer incidence and mortality in Finland, 1963-1995: recent increase in cervical cancer incidence. Int. J. Cancer 1999; 83: 59-65.
Hakama, M.: Syöpäseulonnat. In: Syöpätaudit. Eds. H. Joensuu, P.J. Roberts and L. Teppo. Kustannus Oy Duodecim, Vammala 1999, pp. 51-59. (in Finnish)
Hakama, M., Pukkala, E., Söderman, B. and Day, N.: Implementation of screening as a public health policy: issues in design and evaluation. J. Med. Screen. 1999; 6: 209-216.
Heikkilä, R., Aho, K., Heliövaara, M., Hakama, M., Marniemi, J., Reunanen, A. and Knekt, P.: Serum testosterone and sex hormone-binding globulin concentrations and the risk of prostate carcinoma. Cancer 1999; 86: 312-315.
Holli, K., Visakorpi, T. and Hakama, M.: Smoking and survival from lung cancer. Acta Oncol. 1999; 38: 989-992.
Leivo, T., Salminen, T., Sintonen, H., Tuominen, R., Auerma, K., Partanen, K., Saari, U., Hakama, M. and Heinonen, O.-P.: Incremental cost-effectiveness of double-reading mammograms. Breast Cancer Res. Treat. 1999; 54: 261-267.
Leivo, T., Sintonen, H., Tuominen, R., Hakama, M., Pukkala, E. and Heinonen, O.-P.: The cost-effectiveness of nationwide breast carcinoma screening in Finland, 1987-1992. Cancer 1999; 86: 638-646.
Luostarinen, T., af Geijersstam, V., Björge, T., Eklund, C., Hakama, M., Hakulinen, T., Jellum, E., Koskela, P., Paavonen, J., Pukkala, E., Schiller, J.T., Thoresen, S., Youngman, L.D., Dillner, J. and Lehtinen, M.: No excess risk of cervical carcinoma among women seropositive for both HPV16 nad HPV6/11. Int. J. Cancer 1999; 80: 818-822.
Matthew, A., Rajan, B., Ganesh, B. and Hakama, M.: Cancer survival estiamtion: Teh need to correct bias due outcome- related follow up loss. Natl. Med. J. India 1999;12: 89-90.
Määttänen, L., Auvinen, A., Stenman, U.-H., Rannikko, S., Tammela, T., Aro, J., Juusela, H. and Hakama, M.: European randomized study of prostate cancer screening: first-year results of the Finnish trial. Br. J. Cancer 1999; 79: 1210-1214.
Nieminen, P., Kallio, M., Anttila, A. and Hakama, M.: Organised vs. spontaneous Pap-smear screening for cervical cancer: A case-control study. Int. J. Cancer 1999; 83: 55-58.
Saarenmaa, I., Salminen, T., Geiger, U., Holli, K., Isola, J., Kärkkäinen, A., Pakkanen, J., Piironen, A., Salo, A. and Hakama, M.: The visibility of cancer on earlier mammograms in a population-based screening programme. Eur. J. Cancer 1999; 35: 1118-1122.
Salminen, T.M., Saarenmaa, I.E., Heikkilä, M.M. and Hakama, M.: Unfavourable change in mammographic patterns and the breast cancer risk fackors. Breast Cancer Res. Treat. 1999; 57: 165-173.
Viikki, M., Pukkala, E. and Hakama, M.: Risk of cervical cancer after a negative Pap smear. J. Med. Screen. 1999; 6: 203-107.
Anttila, A., Pukkala, E., Nieminen, P. and Hakama, M.: Kohdunkaulan syövän ilmaantuvuus on Suomessa selvästi suurenemassa. Duodecim 1998; 114: 1117-1124. (in Finnish)
Auvinen, A., Hakama, M. and Rytömaa, T.: Pieniannoksinen ionisoiva säteily ja syöpävaara. Duodecim 1998; 114: 505-507.
Auvinen, A., Mäkeläinen, I., Hakama, M., Castren, O., Pukkala, E., Reisbacka, H. and Rytömaa, T.: Erratum (referring to Auvinen et al.: J. Natl. Cancer Inst. 1996: 88: 966-972. J. Natl. Cancer Inst. 1998; 90: 401-402.
Hakama, M.: Chemoprevention of cancer. Acta Oncol. 1998; 37: 227-230.
Hakama, M. and Auvinen, A.: Effects of the Chernobyl accident in Finland. In: WHO/HICARE Symposium on Radiological Accidents and Environmental Epidemiology: A Decade after the Chernobyl Accident. Proceedings. Hiroshima International Council for Health Care of the Radiation-Exposed and World Health Organization, Geneva 1998, pp. 57-61.
Hakama, M. and Hristova, L.: Inverkan av screening i nordisk cancerkontroll fram till år 2017. In: Kræftbilledet i Norden. Nordisk Ministerråd. TemaNord 501. Copenhagen 1998; 49-70. (in Swedish)
Holli, K., Saaristo, R., Isola, J., Hyöty, M. and Hakama, M.: Effect of radiotherapy on the interpreation of routine follw-up mammography after conservative breast surgery. A randomized study. Br. J. Cancer 1998; 78: 542-545.
Kallio, M. and Hakama, M.: Kohdunkaulan syöpä- ja esiastelöydökset seulonnoissa. Suom. Lääk.-L. 1998; 53: 2409-2411. (in Finnish)
Knekt, P., Hakama, M., Järvinen, R., Pukkala, E. and Heliövaara, M.: Smoking and risk of colorectal cancer. Br. J. Cancer 1998; 78: 136-139.
Koskimäki, J., Hakama, M., Huhtala, H. and Tammela, T.J.L.: Association of smoking with lower urinary tract symptoms. J. Urol. 1998; 158: 1580-1582.
Koskimäki, J., Hakama, M., Huhtala, H. and Tammela, T.L.J.: Prevalence of lower urinary tract symptoms in Finnish men: A population-based study. Brit. J. Urol. 1998; 78: 542-545.
Salminen, T., Hakama, M., Heikkilä, M. and Saarenmaa, I.: Favorable change in mammographic parenchymal patterns and breast cancer risk factors. Int. J. Cancer 1998; 78: 410-414.
Salminen, T.M., Saarenmaa, I.E., Heikkilä, M. and Hakama, M.: Risk of breast cancer and changes in mammographic parenchymal patterns over time. Acta Oncol. 1998; 37: 547-551.
Teppo, L., Hakama, M. and Sankila, R.: Finnish Cancer Registry, 1980-1989. In: International Incidence of Childhood Cancer, Vol. II. Eds. D.M. Parkin, E. Kramarova, G.J. Draper, E. Masuyer, J. Michaelis, J. Neglia, S. Qureshi, C.A. Stiller. IARC Scientific Publications No. 144, Lyon 1998, pp. 261-263.
Viikki, M., Pukkala, E. and Hakama, M.: Bleeding symptoms and subsequent risk of gynecological and other cancers. Acta Obstet. Gynecol. Scand. 1998; 77: 564-569.
Viikki, M., Pukkala, E. and Hakama, M.: Risk of endometrial, ovarian, vulvar and vaginal cancers after a postive cervical cytology followed by negative histology. Obstet. Gynecol. 1998; 92: 269-273.
Auvinen, A., Mäkeläinen, I., Hakama, M., Castren, O., Pukkala, E., Reisbacka, H. and Rytömaa, T.: Response: (Authors' reply to a letter to the Editor on paper published by Auvinen et al.: J. Natl. Cancer Inst. 1996: 88: 966-972.) J. Natl. Cancer Inst. 1997; 89: 584-585.
Dillner, J., Lehtinen, M., Björge, T., Luostarinen, T., Youngman, L., Jellum, E., Koskela, P., Gislefoss, R.E., Hallmans, G., Paavonen, J., Sapp, M., Schiller, J. T., Hakulinen, T., Thoresen, S. and Hakama, M.: Prospective seroepidemiologic study of human papillomavirus infection as a risk factor for invasive cervical cancer. J. Natl. Cancer Inst. 1997; 89: 1293-1299.
Hakama, M.: Chemoprevention research in Europe. Int. J. Cancer 1997; Suppl. 10: 30-33.
Hakama, M.: Randomized preventive trials in the world. Jpn. J. Cancer Clin. 1997; 43: 369-374.
Hakama, M.: Screening for cervical cancer: Experience of the Nordic countries. In: New Developments in Cervical Cancer Screening and Prevention. Eds. E. Franco and J. Monsonego. Blackwell Science 1997, pp. 190-199.
Hakama, M., Auvinen, A., Rannikko, S. and Tammela, T.: Toinen vastine Sakselalle. Duodecim 1997; 113: 538-539. (in Finnish)
Hakama, M. and Hristova, L.: Effect of screening in the Nordic cancer control up to the year 2017. Acta Oncol. 1997; 36: 119-128.
Hakama, M., Pukkala, E., Heikkilä, M. and Kallio, M.: Effectiveness of the public health policy for breast cancer screening in Finland: population based cohort study. Brit. Med. J. 1997; 314: 864-867.
Hakama, M., Pukkala, E., Kallio, M. and Heikkilä, M.: Mammografiaseulonnan vaikuttavuus Suomessa. Duodecim 1997; 113: 2171-2173. (in Finnish)
Hokkanen, T., Hemminki, E., Aalto, P., Hakama, M., Huhtala, H., Jylhä, M., Karjalainen, S. and Tuimala, R.: Patient managed clinical trials. Contr. Clin. Trials 1997; 18: 140-150.
Holli, K., Saaristo, R., Isola, J. and Hakama, M.: Consistency of patient- and doctor-assessed cosmetic outcome after conservative treatment of breast cancer. Breast Cancer Res. Treat. 1997; 45: 225-228.
Hristova, L. and Hakama, M.: Effect of screening for cancer in the Nordic countries on deaths, costs and quality of life up to the year 2017. Acta Oncol. 1997; 36: Suppl. 9.
Luoto, R., Auvinen, A., Pukkala, E. and Hakama, M.: Hysterectomy and subsequent risk of cancer. Int. J. Epidemiol. 1997; 26: 476-483.
Aromaa, A., Kosunen, T.U., Knekt, P., Maatela, J., Teppo, L., Heinonen, O.P., Härkönen, M. and Hakama, M.K.: Circulating anti-Helicobacter pylori immunoglobulin A antibodies and low serum pepsinogen I level are associated with increased risk of gastric cancer. Am. J. epidemiol. 1996; 144: 142-149
Auvinen, A., Elovainio, L. and Hakama, M.: Breast self-examination and survival from breast cancer. Breast Cancer Res. Treat. 1996; 38: 161-168.
Auvinen, A., Hakama, M., Rannikko, S., Stenman, U.-H. and Tammela, T.: Onko Suomessa perusteita eturauhassyövän seulonnalle? Duodecim 1996; 112: 1241-1243. (in Finnish)
Auvinen, A., Mäkeläinen, I., Hakama, M., Castrén, O., Pukkala, E., Reisbacka, H. and Rytömaa, T.: Indoor radon exposure and risk of lung cancer: a nested case-control study in Finland. J. Natl. Cancer Inst. 1996; 88: 966-972.
Auvinen, A., Tammela, T., Stenman, U.-H., Uusi-Erkkilä, I., Leinonen, J., Schröder, F.H. and Hakama, M.: Screening for prostate cancer using serum prostate-specific antigen: a randomised, population-based pilot study in Finland. Br. J. Cancer 1996; 74: 568-572.
Hakama, M.: Current strategies for cancer prevention: Chemoprevention. J. Epidemiol. 1996; 6: S39-S42.
Hakama, M.: Screening for cervical cancer. In: Advances in cancer screening. Ed. A.B. Miller. Kluwer Academic Publishers, Boston 1996, pp. 41-49.
Hakama, M.: Why chemoprevention? In: Chemoprevention in cancer control. Ed. M. Hakama, V. Beral, E. Buiatti, J. Faivre and D.M. Parkin. IARC Scientific Publications No. 136. IARC, Lyon 1996, pp. 1-5.
Hakama, M., Beral, V., Buiatti, E., Faivre, J. and Parkin, D.M.: Chemoprevention in cancer control. IARC Scientific Publications No. 136. IARC, Lyon 1996.
Hakama, M., Holli, K., Visakorpi, T., Pekola, M. and Kallioniemi, O.-P.: Low biological aggressiveness of screen-detected lung cancers may indicate over-diagnosis. Int. J. Cancer 1996; 66: 6-10.
Hakama, M., Stenman, U.-H., Knekt, P., Järvisalo, J., Hakulinen, T., Maatela, J. and Aromaa, A.: CA 125 as a screening test for ovarian cancer. J. Med. Screen. 1996; 3: 40-42.
Holli, K., Hakama, M. and Hakala, T.: Use of hospital services by breast cancer patients by stage of the disease: implicaitons on the costs of cancer control. Breast Cancer Res. Treat. 1996; 37: 237-241.
Knekt, P., Aromaa, A., Alfthan, G., Maatela, J., Hakama, M., Hakulinen, T. and Teppo, L.: Prospective study of serum micronutrients and ovarian cancer. J. Natl. Cancer Inst. 1996; 19: 1408.
Lehtinen, M., Dillner, J., Knekt, P., Luostarinen, T., Aromaa, A., Krinbauer, R., Koskela, P., Paavonen, J., Peto, R., Schiller, J.T. and Hakama, M.: Serologically diagnosed infection with human papillomavirus type 16 and and risk for subsequent development of cervical carcinoma: nested case-control study. Brit. Med. J. 1996; 312: 537-539.
Lehtinen, T., Luostarinen, T., Dillner, J., Aromaa, A., Hakama, M., Hakulinen, T., Knekt, P., Leinikki, P., Lumio, J., Lähdeaho, M.-L., Maatela, J., Teppo, L. and Lehtinen, M.: Serum p53 accumulation and altered antibody responses to Epstein-Barr virus proteins precede diagnosis of haemopoetic malignancies of lymphoid origin. Brit. J. Haematol. 1996; 93: 104-110.
Ruosteenoja, E., Mäkeläinen, I., Rytömaa, T., Hakulinen, T. and Hakama, M.: Radon and lung cancer in Finland. Health Phys. 1996; 71: 185-189.
Hakama, M.: Population breast-cancer screening. Letters to the Editor, and Author's reply. Lancet 1995; 345: 853-855.
Hakama, M., Holli, K., Isola, J., Kallioniemi, O.-P., Kärkkäinen, A., Visakorpi, T., Pukkala, E., Saarenmaa, I., Geiger, U., Ikkala, J., Nieminen, T., Godenhjelm, K. and Koivula, T.: Aggressiveness of screen-detected breast cancers. Lancet 1995; 345: 221-224.
Hakama, M., Kallio, M. and Pukkala, E.: Kohdunkaulan syövän seulonnat - vaikuttavia vai oikeudenmukaisia? Suom. Lääk.-L. 1995; 50: 2527-2533. (in Finnish)
Hakama, M., Pukkala, E., Kallio, M., Godenhjelm, K. and Svinhufvud, U.: Effectiveness of screening for breast cancer in women under 50 years at entry: The Kotka pilot project in Finland. Int. J. Cancer 1995; 63: 55-57.
Holli, K., Isola, J. and Hakama, M.: Prognostic effect of timing of operation in relation to menstrual phase of breast cancer patient - fact or fallacy. Br. J. Cancer 1995; 71: 124-127.
Kallio, M., Nieminen, P. and Hakama, M.: Kohdunkaulan syövän seulontojen vaikuttavuus Suomessa. Duodecim 1995; 111: 227-231. (in Finnish)
Nieminen, P., Kallio, M. and Hakama, M.: Kohdunkaulan adenokarsinooman esiintyvyys Suomessa. Duodecim 1995; 111: 837-841. (in Finnish)
Nieminen, P., Kallio, M. and Hakama, M.: The effect of mass screening on incidence and mortality of squamous and adenocarcinoma of cervix uteri. Obstet. Gynecol. 1995; 85: 1017-1021.
Visakorpi, T., Holli, K. and Hakama, M.: High cell proliferation activity determined by DNA flow cytometry and prognosis in epidermoid lung carcinoma. Acta Oncol. 1995; 34: 605-609.
Auvinen, A., Hakama, M., Arvela, H., Hakulinen, T., Rahola, T., Suomela, M., Söderman, B. and Rytömaa, T.: Fallout from Chernobyl and incidence of childhood leukaemia in Finland, 1976-92. Brit. Med. J. 1994; 309: 151-154.
Auvinen, A., Isola, J., Visakorpi, T., Koivula, T., Virtanen, S. and Hakama, M.: Overexpression of p53 and long-term survival in colon carcinoma. Br. J. Cancer 1994; 70: 293-296.
Auvinen, A., Rahola, T., Arvela, H., Suomela, M., Rytömaa, T., Hakama, M., Hakulinen, T. and Söderman, B.: Authors' reply (Letter to the Editor: Studies may have had inadequate statistical power). Brit. Med. J. 1994; 1300-1301.
Gästrin, G., Miller, A.B., To, T., Aronson, K.J., Wall, C., Hakama, M., Louhivuori, K. and Pukkala, E.: Inicidence and mortality from breast cancer in the mama program for breast screening in Finland, 1973-1986. Cancer 1994; 73: 2168-2174.
Hakama, M., Stenman, U.-H., Knekt, P., Järvisalo, J., Leino, A., Hakulinen, T., Maatela, J. and Aromaa, A.: Tumour markers and screening for gastrointestinal cancer: a follow-up study in Finland. J. Med. Screen. 1994; 1: 60-64.
Kallio, M., Kauraniemi, T., Nousiainen, A.-R., Hansten, S., Rytsölä, J., Heikkilä, M. and Hakama, M.: Naisten osallistuminen kohdunkaulan syövän seulontoihin. Duodecim 1994; 110: 1061-1067. (in Finnish)
Lehtinen, M., Dillner, J., Aromaa, A., Aaran, R.-K., Hakulinen, T., Knekt, P., Leinikki, P., Luostarinen, T., Maatela, J., Paavonen, J. and Hakama, M.: IgG antibodies to human papillomavirus type 16 and serum retinol may jointly protect against cervical neoplasia. In: Immunology of Human Papillomaviruses. Ed. M.A. Stanley. Plenum Press, New York, 1994, pp. 113-118.
Lehtinen, T., Lehtinen, M., Luostarinen, T., Dillner, J., Hakama, M., Hakulinen, T., Knekt, P., Leinikki, P., Maatela, J. and Teppo, L.: Accumulation of serum p53 and high EBNA antibody levels preceding diagnosis of lymphoid malignancies. In: Proceedings of the XVI International Cancer Congress, New Delhi (India), October 30 - November 5, 1994. Eds. R.S. Rao, M.G. Deo and L.D. Sanghvi. Monduzzi Editore, Bologna 1994, pp. 2535-2539.
Meurman, L.O., Pukkala, E. and Hakama, M.: Incidence of cancer among anthophyllite asbestos miners in Finland. Occup. Environ. Med. 1994; 51: 421-425.
Stenman, U.-H., Hakama, M., Knekt, P., Aromaa, A., Teppo, L. and Leinonen, J.: Serum concentrations of prostate specific antigen and its complex with alfa 1 -antichymotrypsin before diagnosis of prostate cancer. Lancet 1994; 344: 1594-1598.
Aareleid, T., Pukkala, E., Thomson, H. and Hakama, M.: Cervical cancer incidence and mortality trends in Finland and Estonia: A screened vs. an unscreened population. Eur. J. Cancer 1993; 29A: 745-749.
Aareleid, T., Thomson, H., Pukkala, E. and Hakama, M.: Emakakaelavähk Eestis ja Soomes: ajalise trendi erinevused. (Cervical cancer in Estonia and Finland: Differences of time trends.) Eesti Arst 1993; No. 1: 7-11. (in Estonian, with English summary)
Hakama, M.: Breast cancer screening with mammography. Lancet 1993; 341: 1531.
Hakama, M.: Potential contribution of screening to cancer mortality reduction. Cancer Detect. Prev. 1993; 17: 513-520.
Hakama, M.: To screen or not to screen for cervical cancer. Eur. J. Cancer 1993; 29A: 2218-2220.
Hakama, M., Beral, V. and Parkin, M.: Prevention of digestive cancers - The UICC project on evaluation of primary prevention. In. Recent Advances in Management of Digestive Cancers. Ed. T. Takahashi. Proceedings of UICC Kyoto International Symposium on Recent Advances in Management of Digestive Cancers, March 31-April 2, 1993. Springer-Verlag, Tokyo 1993, pp. 38-45.
Hakama, M., Lehtinen, M., Knekt, P., Aromaa, A., Leinikki, P., Miettinen, A., Paavonen, J., Peto, R. and Teppo, L.: Serum antibodies and subsequent cervical neoplasms: A prospective study with 12 years of follow-up. Am. J. Epidemiol. 1993; 137: 166-170.
Holli, K. and Hakama, M.: Biological, physical, mental and social dimensions of breast cancer: Information based on routine case notes. Eur. J. Cancer 1993; 29A: 2152-2155.
Järvisalo, J., Hakama, M., Knekt, P., Stenman, U.-H., Leino, A., Teppo, L., Maatela, J. and Aromaa, A.: Serum tumor markers CEA, CA 50, TATI, and NSE in lung cancer screening. Cancer 1993; 71: 1982-1988.
Lehtinen, T., Lumio, J., Dillner, J., Hakama, M., Knekt, P., Lehtinen, M., Teppo, L. and Leinikki, P.: Increased risk of malignant lymphoma indicated by elevated Epstein-Barr virus antibodies - a prospective study. Cancer Causes Control 1993; 4: 187-193.
Sankila, R. and Hakama, M.: Survival trends for neuroblastoma patients in Finland: Negative reflections on screening. Eur. J. Cancer 1993; 29A: 122-123.
Auvinen, A., Rytömaa, T., Arvela, H. and Hakama, M.: Follow-up for the health effects of Chernobyl fall-out in Finland. In: Workshop on the Long Term Follow up of the Chernobyl Disaster. 6-8 December 1991, Athens, International Union Against Cancer, Hellenic Cancer Society in cooperation with W.H.O., Athens 1992 p. 45-51.
Hakama, M.: Costs and benefits, quality controls, methods, perspectives of screening: contributions from Finland. In: Recent Advances in Cervical Pathology and Colposcopy. Ed. L. Carenza, G. Atlante and V. Pozzi. Advances in Gynecological and Obstetric Research Series, Vol. 3. The Parthenon Publishing Group, Lancs 1992, pp. 361-365.
Hakama, M.: Syöpäseulonnat. In: Syöpätaudit. Ed. L.R. Holsti, P.J. Roberts and L. Teppo. Kustannus Oy Duodecim, Vammala 1992, pp. 39-46. (in Finnish)
Hakama, M. and Hakulinen, T.: Trends and projections in cancer risk in Finland. In: Geriatric Oncology. Ed. L. Balducci, G.H. Lyman and W.B. Ershler. J.B. Lippincott Company, Philadelphia 1992, pp. 370-374.
Kaldor, J.M., Day, N.E., Bell, J., Clarke, E.A., Langmark, F., Karjalainen, S., Band, P., Pedersen, D., Choi, W., Blair, V., Henry-Amar, M., Prior, P., Assouline, D., Pompe-Kirn, V., Cartwright, R.A., Koch, M., Arslan, A., Fraser, P., Sutcliffe, S.B., Host, H., Hakama, M. and Stovall, M.: Lung cancer following Hodgkin's disease: A case-control study. Int. J. Cancer 1992; 52: 677-681.
Knekt, P., Aromaa, A., Maatela, J., Rissanen, A., Hakama, M., Aaran, R.-K., Nikkari, T., Hakulinen, T., Peto, R. and Teppo, L.: Serum ceruloplasmin and the risk of cancer in Finland. Br. J. Cancer 1992; 65: 292-296.
Lehtinen, M., Hakama, M., Aaran, R.-K., Aromaa, A., Knekt, P., Leinikki, P., Maatela, J., Peto, R. and Teppo, L.: Herpes simplex virus type 2 infection and cervical cancer: a prospective study of 12 years of follow-up in Finland. Cancer Causes Control 1992; 3: 333-338.
Sankila, R. and Hakama, M.: Neuroblastoomaseulontaa ei tarvita Suomeen. Duodecim 1992; 108: 873-878. (in Finnish)
Thomas, D.B., Hakama, M., Bodo, M., Hakulinen, T., Havriliuc, C., Komarova, L., Semiglasov, V. and Vuletic, L.: Screening. The Working Group on Screening. In: Cancer Prevention in Europe. International Meeting, All-Union Cancer Research Centre, Moscow, USSR, 2-4 September, 1991. Organization of European Cancer Institutes, Geneva 1992, pp. 199-218.
Elovainio, L., Hakama, M. and Huttunen, J.: Pitääkö mammografiaseulonta ulottaa alle 50-vuotiaisiin naisiin. Suom. Lääk.-L. 1991; 46: 2071-2072.screening (in Finnish)
Hakama, M.: Screening for breast cancer in Finland. In: Cancer Screening. Ed. A.B. Miller, J. Chamberlein, N.E. Day, M. Hakama and P.C. Prorock. Cambridge University Press, Cambridge 1991, pp. 18-22.
Hakama, M.: Screening. In: Oxford Textbook of Public Health. Vol. 3. Applications in Public Health. 2nd ed. Ed. W.W. Holland, R. Detels and G. Knox. Oxford University Press, Oxford 1991, pp. 91-106.
Hakama, M.: Syöpäseulonnat: hyödyksi vai haitaksi? Duodecim 1991; 107: 1148-1151. (in Finnish)
Hakama, M.: Tilastotiede ja lääketiede. In: Suomen Tilastoseura 70 vuotta. Ed. I. Mellin. Publications issued by the Finnish Statistical Society No. 7. Helsinki 1991, pp. 191-192. (in Finnish, with English summary)
Hakama, M., Elovainio, L., Kajantie, R. and Louhivuori, K.: Breast cancer screening as public health policy in Finland. Br. J. Cancer 1991; 64: 962-964.
Hakama, M., Magnus, K., Pettersson, F., Storm, H. and Tulinius, H.: Effect of organized screening on the risk of cervical cancer in the Nordic countries. In: Cancer Screening. Ed. A.B. Miller, J. Chamberlain, N.E. Day, Hakama, M. and P.C. Prorok. Cambridge University Press, Cambridge 1991, pp. 153-162.
Hakulinen, T. and Hakama, M.: Predictions of epidemiology and the evaluation of cancer control measures and the setting of policy priorities. Soc. Sci. Med. 1991; 33: 1379-1383.
Holli, K. and Hakama, M.: Terminal stages of breast cancer: Changes in clinical practice. Eur. J. Cancer 1991; 27: 1338-1339.
Knekt, P., Aromaa, A., Maatela, J., Aaran, R.-K., Nikkari, T., Hakama, M., Hakulinen, T., Peto, R. and Teppo, L.: Vitamin E and cancer prevention. Am. J. Clin. Nutr. 1991; 53: 283S-286S.
Knekt, P., Aromaa, A., Maatela, J., Alfthan, G., Aaran, R.-K., Nikkari, T., Hakama, M., Hakulinen, T. and Teppo, L.: Serum micronutrients and risk of cancers of low incidence in Finland. Am. J. Epidemiol. 1991; 134: 356-361.
Miller, A.B., Chamberlain, J., Day, N.E., Hakama, M. and Prorok, P.C.: Cancer Screening. UICC Project on Evaluation of Screening for Cancer. International Union Against Cancer, Cambridge 1991.
Auvinen, A., Elovainio, L. and Hakama, M.: Miten rintasyöpä löytyi. (How was breast cancer detected.) Sosiaalilääketiet. Aik.-L. 1990; 27: 306-313.Journal of Social Medicine. (in Finnish, with English summary)
Hakama, M.: A screening programme that worked: discussion paper. J. Roy. Soc. Med. 1990; 83: 322-324.
Hakama, M.: Epidemiologinen syöpätutkimus. Syöpä 1990; No. 1: 20-21. (in Finnish)
Hakama, M.: Screening for cervical cancer. In: Cancer Prevention. Vital Statistics to Intervention. Proceedings of the International Coference, 12-14 October 1988, Warsaw, Poland. Ed. W. Zatonski, P. Boyle and J. Tyczynski. PA Interpress, Warsaw 1990, pp. 122-124.
Hakama, M., Aaran, R.-K., Alfthan, G., Aromaa, A., Hakulinen, T., Knekt, P., Maatela, J., Nikkari, T., Peto, R. and Teppo, L.: Linkage of serum sample bank and cancer registry in epidemiological studies. In: Recent Progress in Research on Nutrition and Cancer. Ed. C.J. Mettlin and K. Aoki. Progress in Clinical and Biological Research, Vol. 346. Wiley-Liss, Inc. New York 1990, pp. 169-178.
Hakama, M., Beral, V., Cullen, J. and Parkin, M.: Evaluation of primary cancer prevention programs. In: Epidemiology & Prevention of Cancer. Ed. R. Sasaki and K. Aoki. The University of Nagoya Press. Nagoya 1990, pp. 234-238.
Hakama, M., Beral, V., Cullen, J. and Parkin, M.D. (Ed.): Evaluating Effectiveness of Primary Prevention of Cancer. IARC Scientific Publications No. 103. IARC, Lyon 1990.
Hakama, M. and Holli, K.: Millainen on rintasyövän oikea hoito? Duodecim 1990; 106: 907-909. (in Finnish)
Holli, K., Hakama, M. and Mooney, G.: Changing clinical pratice: A case study in breast cancer. In: Changing Values in Medical and Health Care Decision Making. Ed. U.J. Jensen and G. Mooney. John Wiley, New York 1990, pp. 123-130.
Knekt, P., Aromaa, A., Maatela, J., Aaran, R.-K., Nikkari, T., Hakama, M., Hakulinen, T., Peto, R. and Teppo, L.: Serum vitamin A and subsequent risk of cancer: cancer incidence follow-up of the Finnish Mobile Clinic Health Examination Survey. Am. J. Epidemiol. 1990; 132: 857-870.
Knekt, P., Aromaa, A., Maatela, J., Alfthan, G., Aaran, R.-K., Hakama, M., Hakulinen, T., Peto, R. and Teppo, L.: Serum selenium and subsequent risk of cancer among Finnish men and women. J. Natl. Cancer Inst. 1990; 82: 864-868.
Miller, A.B., Chamberlain, J., Day, N.E., Hakama, M. and Prorok, P.C.: Report on a workshop of the project on evaluation of screening for cancer. Int. J. Cancer 1990; 46: 761-769.
Ruosteenoja, E., Hakama, M., Mäkeläinen, I. and Rytömaa, T.: Risk of lung cancer in southeastern Finland in relation to radon exposure in dwellings. In. Radiation and Cancer Risk. Ed. T. Brustad, F. Langmark and J.B. Reitan. The Cancer Series. Hemisphere, New York 1990, pp. 43-47.
Rutqvist, L.E., Miller, A.B., Andersson, I., Hakama, M., Hakulinen, T., Sigfusson, B.F. and Tabar, L.: Reduced breast-cancer mortality with mammography screening - an assessment of of currently available data. In: Breast cancer, Critical Overviews of Natural Hirtory, Etiology, Molecular Biology and Screening by Mammography. Ed. J. Pontén and L.-G. Larsson. Int. J. Cancer 1990; Suppl. 5: 76-84.
Sankila, R., Karjalainen, S., Pukkala, E., Oksanen, H., Hakulinen, T., Teppo, L. and Hakama, M.: Cancer risk among glass factory workers: an excess of lung cancer. Br. J. Ind. Med. 1990; 47: 815-818.
Syrjänen, K., Hakama, M., Saarikoski, S., Väyrynen, M., Ylikoski, M., Syrjänen, S., Kataja, V. and Castrén, O.: Prevalence, incidence, and estimated life-time risk of cervical human papillomavirus infections in a nonselected Finnish female population. Sex. Transm. Dis. 1990; 17: 15-19.
Elovainio, L., Kajantie, R., Louhivuori, K. and Hakama, M.: Syöpäjärjestöjen rintasyöpäseulonnat 1987. Duodecim 1989; 105: 1184-1190. (in Finnish)
Hakama, M., Beral, V., Cullen, J. and Parkin, M.: UICC workshop on evaluating interventions to reduce cancer risk. Int. J. Cancer 1989; 43: 967-969.
Hakama, M., Elovainio, L. and Leppo, K.: Pitääkö rintasyövän seulontoja jatkaa? Duodecim 1989; 105: 1164-1167. (in Finnish)
Hakama, M., Karjalainen, S. and Hakulinen, T.: Outcome-based equity in the treatment of colon cancer patients in Finland. Int. J. Technol. Ass. Hlth Care 1989; 22: 123-134.
Hakama, M. and Louhivuori, K.: Epidemiology, screening and survival of breast cancer in Finland. In: Cancer in the USSR and Finland. Collection of Scientific Works. USSR Ministry of Health, Petrov Research Institute of Oncology and Cancer Society of Finland - Finnish Cancer Registry. Leningrad 1989, pp. 63-76. (in Russian, with English summary)
Holli, K. and Hakama, M.: Effectiveness of routine and spontaneous follow-up for breast cancer. Eur. J. Cancer Clin. Oncol. 1989; 25: 251-254.
Holli, K. and Hakama, M.: Treatment of the terminal stages of breast cancer. Brit. Med. J. 1989; 298: 13-14.
Kallioniemi, O.-P., Kärkkäinen, A., Mattila, J., Auvinen, O., Koivula, T. and Hakama, M.: Mammografiaseulonnassa todettavien rintasyöpien biologiset ominaisuudet - virtaussytometrinen tutkimus. Duodecim 1989; 105: 1532-1538. (in Finnish)
Knekt, P., Alfthan, G., Aromaa, A., Hakama, M., Hakulinen, T., Maatela, J., Peto, R., Saxén, E. and Teppo, L.: Low selenium level and elevated risk of lung cancer. In: Selenium in Biology and Medicine. Ed. Wendel. A. Springer-Verlag, Heidelberg 1989, pp. 313-316.
Lehtinen, M., Hakama, M., Knekt, P., Heinonen, P.K., Lehtinen, T., Paavonen, J., Teppo, L. and Leinikki, P.: Lack of serum antibodies to the major HSV-2 specified DNA-binding protein before diagnosis of cervical neoplasia. J. Med. Virol. 1989; 27: 131-136.
Aaran, R.-K., Lehtinen, M., Knekt, P., Aromaa, A. and Hakama, M.: Carcinoembryonic antigen levels in sera drawn 1 to 12 years before diagnosis of cervical malignancy. Cancer Detect. Prev. 1988; 13: 9-12.
Hakama, M.: Design of the Finnish Breast Cancer Screening Study. In: Screening for Breast Cancer. Ed. N. Day and A. B. Miller. Based on a workshop held in Helsinki 1986. Hans Huber, Toronto 1988, pp. 59-62.
Hakama, M.: Epidemiologisten indikaattorien tulkinnasta. (Reading of epidemiologic papers.) Sosiaalilääketiet. Aik.-L. 1988; 25: 23-26.Journal of Social Medicine. (in Finnish, with English summary)
Hakama, M.: Kontrolloidut kokeet ja niiden suunnnittelu. Duodecim 1988; 104: 26-33. (in Finnish)
Hakama, M. and Louhivuori, K.: A screening programme for cervical cancer that worked. Cancer Surveys 1988; 7: 403-416.
Hakama, M. and Louhivuori, K.: Is there today an epidemic outbreak of cancer of the uterine cervix? In: Herpes and Papilloma Viruses. Their Role in the Carcinogenesis of the Lower Genital Tract. Vol. II. Ed. G. De Palo, F. Rilke and H. zur Hausen. Serono Symposia Publications from Raven Press. Volume 46. New York 1988, pp. 91-96.
Hakama, M. and Pukkala, E.: Evaluation of an immunological screening for stomach cancer. In: Screening for Gastrointestinal Cancer. Ed. J. Chamberlain and A. B. Miller. A report of a UICC International Workshop, Gothenburg 1985. Hans Huber, Toronto 1988, pp. 71-75.
Kallioniemi, O.-P., Kärkkäinen, A., Auvinen, O., Mattila, J., Koivula, T. and Hakama, M.: DNA flow cytometric analysis indicates that many breast cancers detected in the first round of mammographic screening have a low malignant potential. Int. J. Cancer 1988; 1988: 42: 697-702.
Karjalainen, S. and Hakama, M.: Alueelliset erot syöpäpotilaiden eloonjäämisluvuissa. Suom. Lääk.-L. 1988; 43: 2054-2061. (in Finnish)
Knekt, P., Aromaa, A., Maatela, J., Aaran, R.-K., Nikkari, T., Hakama, M., Hakulinen, T., Peto, R., Saxén, E. and Teppo, L.: Serum vitamin E and risk of cancer among Finnish men during a 10-year follow-up. Am. J. Epidemiol. 1998; 127: 28-41.
Knekt, P., Aromaa, A., Maatela, J., Alfthan, G., Aaran, R.-K., Teppo, L. and Hakama, M.: Serum vitamin E, serum selenium and the risk of gastrointestinal cancer. Int. J. Cancer 1988; 42: 846-850.
Knekt, P., Reunanen, A., Aromaa, A., Heliövaara, M., Hakulinen, T. and Hakama, M.: Serum cholesterol and risk of cancer in a cohort of 39,000 men and women. J. Clin. Epidemiol. 1988; 41: 519-530.
Kärkkäinen, A., Kallioniemi, O.-P. and Hakama, M.: Biological and proliferative characteristics of screen-detected breast tumors as revealed by DNA flow cytometry. In: Mastology '88. Eds. L. Ionnidou-Mouzaka, M. Philippakis and P. Angelakis. Elsevier Science Publishers, Amsterdam 1988, pp. 383-386.
Morrison, A.S., Hakama, M. and Aoki, K.: Meeting report. Seventh Annual Sapporo Cancer Seminar. Primary and secondary prevention of cancer. Cancer Res. 1988; 48: 4434-4436.
Day, N.E. and Hakama, M.: Cervical cancer screening. Lancet 1987; II: 860.
Day, N.E. and Hakama, M.: Screening for cervical cancer. Lancet 1987; II: 210.
Hakama, M.: Miksi rintasyöpää seulotaan. Syöpä 1987; No. 5: 5-6. (in Finnish)
Kaldor, J., Day, N.E., Band, P., Choi, N.W., Clarke, E.A., Coleman, M.P., Hakama, M., Koch, M., Langmark, F., Neal, F.E., Pettersson, F., Pompe-Kirn, V., Prior, P. and Storm, H.H.: Second malignancies following testicular cancer, ovarian cancer and Hodgkin's disease: An international collaborative study among cancer registries. Int. J. Cancer 1987; 39: 571-185.
Kärkkäinen, A., Lauslahti, K., Lehtimäki, V., Schoultz, E., Aine, R. and Hakama, M.: Tampereen rintasyöpäprojektin II kierros: Intervallisyöpien ongelma. Suom. Lääk.-L. 1987; 42: 3128-3132. (in Finnish, with English summary)
Läärä, E., Day, N. and Hakama, M.: Trends in mortality from cervical cancer in the Nordic countries: association with organised screening programmes. Lancet 1987; I: 1247-1249.
Chamberlain, J., Day, N.E., Hakama, M., Miller, A.B. and Prorok P.C.: UICC workshop of the project on evaluation of screening programmes for gastrointestinal cancer. Int. J. Cancer 1986; 37: 329-334.
Day, N.E., Baines, C.J., Chamberlain, J., Hakama, M., Miller, A.B. and Prorok, P.: UICC project on screening for cancer: Report of the workshop on screening for breast cancer. Int. J. Cancer 1986; 38: 303-308.
Hakama, M.: Cervical cancer: risk groups for screening. In: Screening for Cancer of the Uterine Cervix. Ed. M. Hakama, A.B. Miller and N.E. Day. IARC Scientific Publications No. 76. IARC, Lyon 1986, pp. 213-216.
Hakama, M.: Efficacy of screening for cervical cancer. In: Banbury Report 21: Viral Etiology of Cervical Cancer. Cold Spring Harbor Laboratory, Cold Spring Harbor 1986, pp. 45-54.
Hakama, M.: Implications of screening on the biology of cervical cancer. Nowotwory 1986; 36: 1-5.
Hakama, M.: Joukkotarkastuksilla tärkeä osa syöväntorjunnassa. Syöpä 1986; 5: 11-14. (in Finnish)
Hakama, M.: Kokonaistutkimus vai otos. Sosiaalilääketiet. Aik.-L. 1986; 23: 306-308.Journal of Social Medicine. (in Finnish)
Hakama, M.: Scientific basis of screening in early detection. Cancer Detect. Prev. 1986; 9: 139-143.
Hakama, M.: Screening for cancer. Scand. J. Soc. Med. 1986; suppl. 37: 17-25.
Hakama, M., Hakulinen, T. and Läärä, E.: Predicting cancer incidence and prevalence. In: Health Projections in Europe. Methods and Applications. World Health Organization, Regional Office for Europe, Copenhagen 1986, pp. 25-39.
Hakama, M. and Miller, A.B.: Introduction: Report on the workshop on screening for cancer of the cervix. In: Screening for Cancer of the Uterine Cervix. Ed. M. Hakama, A.B. Miller and N.E. Day. IARC Scientific Publications No.76. IARC, Lyon 1986, pp. 147-148.
Lauslahti, K., Kärkkäinen, A., Hartikainen, R.-L., Vekara, L., Aine, R., Auvinen, O., Sulkava, T., Schoulz, E. and Hakama, M.: Tampereen rintasyöpäprojekti. Suom. Lääk.-L. 1986; 41: 1814-1818. (in Finnish)
Lopez, A. and Hakama, M.: Approaches to the projection of health status. In: Health Projections in Europe. Methods and Applications. World Health Organization, Regional Office for Europe, Copenhagen 1986, pp. 9-24.
Boice, J.D., Jr., Day, N.E., Andersen, A., Brinton, L.A., Brown, R., Choi, N.W., Clarke, E.A., Coleman, M.P., Curtis, R.E., Flannery, J.T., Hakama, M., Hakulinen, T., Howe, G.R., Jensen, O.M., Kleinerman, R.A., Magnin, D., Magnus, K., Mäkelä, K., Malker, B., Miller, A.B., Nelson, N., Patterson, C.C., Pettersson, F., Pompe-Kirn, V., Primic-Zakelj, M., Prior, P., Ravnihar, B., Skeet, R.G., Skjerven, J.E., Smith, P.G., Sok, M., Spengler, R.F., Storm, H.H., Stovall, M., Tomkins, G.W.O. and Wall, C.:
Second cancers following radiation treatment for cervical cancer. An international collaboration among cancer registries. J. Natl. Cancer Inst. 1985; 74: 955-975.
Hakama, M.: Effect of population screening for carcinoma of the uterine cervix in Finland. Maturitas 1985; 7: 3-10.
Hakama, M.: Practical experiences with a screening program for cervical cancer in Finland. In: Cancer Campaign. Vol. 8. Cancer of the uterine cervix. Ed. E. Grundmann. Gustav Fischer Verlag, Stuttgart, New York 1985, pp. 41-48.
Hakama, M.: Survival of breast cancer patients in Finland. (Survival of breast cancer patients in Finland.) Vop. Onkol. 1985; 31: 40-44. (in Russian, with English summary)
Hakama, M.: Syöpätautien epidemiologia. In: Syövän biologia. Toim: K. Alitalo, L. Andersson, L. Teppo ja A. Vaheri. WSOY, Porvoo 1985, p. 19-33. (in Finnish)
Hakama, M.: The problem of identification of high-risk subjects for selective screening. In. Screening for Cancer. Ed. A.B. Miller. Academic Press, Orlando 1985, pp. 37-40.
Hakama, M.: Tilastolliset näkökohdat kliinisten tutkimusten suunnittelussa. In: Kliininen tutkimus 1984. Seminaariraportti. Ed. A. Pasternack, H. Frey and A. Kauppila. Suomen Akatemian julkaisuja 1/1985. Valtion lääketieteellinen toimikunta, Helsinki 1985, p. 37-40. (in Finnish)
Hakama, M., Chamberlain, J., Day, N.E., Miller, A.B. and Prorok, P.C.: Evaluation of screening programmes for gynaecological cancer. Br. J. Cancer 1985; 52: 669-673.
Hakulinen, T. and Hakama, M.: The effect of screening on the incidence and mortality of cervical cancer in Finland. Nowotwory 1985; 35: 290-296.
Tenkanen, L., Hakulinen, T., Hakama, M. and Saxén, E.: Sauna, dust and migration as risk factors in lung cancer among smoking and non-smoking males in Finland. Int. J. Cancer 1985; 35: 637-642.
Teppo, L., Hakama, M., Hakulinen, T., Pukkala, E. and Saxén, E.: Planning and evaluating preventive measures. In: The Role of the Registry in Cancer Control. Ed. D. M. Parkin, G. Wagner and C. S. Muir. IARC Scientific Publications No. 66. International Agency for Research on Cancer, Lyon 1985, pp. 27-44.
Boice, J.D., Jr., Day, N.E., Andersen, A., Brinton, L.A., Brown, P., Choi, N.W., Clarke, E.A., Coleman, M.P., Curtis, R.E., Flannery, J.T., Hakama, M., Hakulinen, T., Howe, G.R., Jensen, O.M., Kleinerman, R.A., Magnin, D., Magnus, K., Mäkelä, K., Malker, B., Miller, A.B., Nelson, N., Patterson, C.C., Pettersson, F., Pompe-Kirn, V., Primic-Zakelj, M., Prior, P., Ravnihar, P., Skeet, R.G., Skjerven, J.E., Smith, P.G., Sok, N., Spengler, R.F., Storm, H.H., Tomkins, G.W.O., Wall, C. and Weinstock, R.:
Cancer risk following radiotherapy of cervical cancer: A preliminary report. In: Radiation Carcinogenesis: Epidemiology and Biological Significance. Ed. J.D. Boice, Jr. and J.F. Fraumeni, Jr. Raven Press, New York 1984, pp. 161-179.
Hakama, M.: Selective screening by risk groups. In: Screening for Cancer. I - General Principles on Evaluation of Screening for Cancer and Screening for Lung, Bladder and Oral Cancer. Ed. P.C. Prorock and A.B. Miller. UICC Techn. Rep. Ser., Vol. 78. Geneva 1984, pp. 71-80.
Hakama, M. and Pukkala, E.: L'etablissement de projections pour les maladies chroniques sur la base de chiffres relatifs aux facteurs de risque et aux interventions sur les facteurs de risque: le cas du cancer. Wld Hlth Stat. Quart. 1984; 37: 318-327. (in French)
Hakama, M. and Pukkala, E.: The projection of chronic diseases using data on risk factors and risk factors intervention: the case of cancer. Wld Hlth Stat. Quart. 1984; 37: 318-327.
Prorok, P.C., Chamberlain, J., Day, N.E., Hakama, M. and Miller, A.B.: UICC workshop on the evaluation of screening programmes for cancer. Int. J. Cancer 1984; 34: 1-4.
Day, N.E., Boice, J.D., Andersen, A., Brinton, L.A., Brown, R., Choi, N.W., Clarke, E.A., Coleman, M.P., Curtis, R.E., Flannery, J.T., Hakama, M., Hakulinen, T., Howe, G.R., Jensen, O.M., Kleinerman, R.A., Magnin, D., Magnus, K., Mäkelä, K., Malker, B., Miller, A.B., Nelson, N., Patterson, C.C., Pettersson, F., Pompe-Kirn, V., Primic-Zakelj, M., Prior, P., Ravnihar, P., Skeet, R.G., Skjerven, J.E., Smith, P.G., Sok, M., Spengler, R.F., Storm, H.H., Tomkins, G.W.O. and Wall, C.:
Summary Chapter. In: Second Cancer in Relation to Radiation Treatment for Cervical Cancer. Ed. N.E. Day and J.D. Boice, Jr. IARC Scientific Publications No. 52. IARC, Lyon 1983, pp. 138-181.
Hakama, M.: Cancer of the uterine cervix. In: The Epidemiology of Cancer. Ed. G.J. Bourke. Croom Helm, London & Sydney 1983, pp. 162-175.
Hakama, M.: Epidemiologi raka molocnoj zelezy v Finljandii. (Epidemiology of breast cancer in Finland.) Vop. Onkol. 1983; 29: 41-46. (in Russian, with English summary)
Hakama, M., Hakulinen, T. and Mäkelä, K.: Lisääkö kohdunkaulan syövän sädehoito uuden syövän riskiä? (Radiation and subsequent primary cancers among cervical cancer patients in Finland.) Duodecim 1983; 99: 1463-1467. (in Finnish, with English summary)
Hakama, M., Hakulinen, T. and Mäkelä, K.: Radiation and multiple primary cancers among cervical cancer patients diagnosed in Finland between 1953 and 1977. In: Second Cancer in Relation to Radiation Treatment for Cervical Cancer. Ed. N.E. Day and J.D. Boice, Jr. IARC Scientific Publications No. 52. IARC, Lyon 1983, pp. 77-80.
Hakama, M.: Trends in the incidence of cervical cancer in the Nordic Countries. In: Trends in Cancer Incidence. Causes and Practical Implications. Ed. K. Magnus. Hemisphere Publishing Corporation, New York 1982, pp. 279-292.
Hakama, M., Hakulinen, T., Pukkala, E., Saxén, E. and Teppo, L.: Risk indicators of breast and cervical cancer on ecological and individual level. Am. J. Epidemiol. 1982; 116: 990-1000.
Hakulinen, T., Pukkala, E., Hakama, M., Lehtonen, M., Saxén, E. and Teppo, L.: Syöpäpotilaiden eloonjääminen Suomessa 1953-1974. (Cancer patient survival in Finland in 1953-1974.) Duodecim 1982; 98: 550-562. (in Finnish, with English summary)
Kilpikari, I., Pukkala, E., Lehtonen, M. and Hakama, M.: Cancer incidence among Finnish rubber workers. Int. Arch. Occup. Environ. Health 1982; 51: 65-71.
Hakama, M.: Components of cervical cancer. Lancet 1981; II: 90-91.
Hakama, M.: Seulonnan vaikutus kohdunkaulan syövän ilmaantuvuuteen Pohjoismaissa. (Mass screenings and incidence of cervical cancer in the Nordic countries.) Duodecim 1981; 97: 318-325. (in Finnish)
Hakama, M.: The Finnish experience. (Comment on "Intervals between Pap tests: a compromise") Wld Health Forum 1981; 2: 537-538.
Hakama, M.: Tieto vai epätieto - hoitotutkimuksen tarkastelua. Duodecim 1981; 97: 1200-1203. (in Finnish)
Hakama, M. and Penttinen, J.: Epidemiological evidence for two components of cervical cancer. Brit. J. Obstet. Gynaecol. 1981; 209-214.
Hakulinen, T., Pukkala, E., Hakama, M., Lehtonen, M., Saxén, E. and Teppo, L.: Survival of cancer patients in Finland in 1953-1974. Ann. Clin. Res. 1981; 13: Suppl. 31.
Soini, I., Aine, R., Lauslahti, K. and Hakama, M.: Independent risk factors of benign and malignant breast lesions. Am. J. Epidemiol. 1981; 114: 507-514.
Hakama, M.: Kohdunkaulan syövän joukkotarkastusten tehokkuus. In: Tutkimuksen asein. Syöpätautien Tutkimussäätiö 1969-1979. Syöpätautien Tutkimussäätiö, Turku 1980, p. 13-17. (in Finnish)
Hakama, M.: Projection of cancer incidence: experiences and some results in Finland. Wld Hlth Stat. Quart. 1980; 33: 228-240.
Hakama, M.: Theoretical aspects of breast cancer screening. In: Tidigupptäckt av bröstcancer. Vetenskapligt symposium, Stockholm 1979, Riksförening mot cancer, Stockholm 1980, pp. 144-146. (in Swedish)
Hakama, M.: Uudelle vuosikymmenelle. Sosiaalilääketiet. Aik.-L. 1980; 17: 1-2. (in Finnish, with English summary)
Hakama, M. and Kilpikari, I.: Cancer risk among rubber workers. J. Toxicol. environm. Hlth 1980; 6: 1211-1218.
Hakama, M. and Pukkila, T.: Miesten keuhkosyöpäinsidenssi Suomessa vuonna 2000. (Lung cancer incidence among Finnish males in the year 2000.) Duodecim 1980; 96: 1139-1144. (in Finnish, with English summary)
Hakama, M. and West, R.: Cervical cancer in Finland and South Wales. Implications of end results data on the natural history. J. Epidemiol. Community Health 1980; 34: 14-18.
Soini, I. and Hakama, M.: Effect of a screening programme on breast carcinoma incidence, mortality and survival. Acta Radiol. Oncol. 1980; 19: 255-260.
Teppo, L., Pukkala, E., Hakama, M., Hakulinen, T., Herva, A. and Saxén, E.: Way of life and cancer incidence in Finland. A municipality-based ecological analysis. Scand. J. Soc. Med. 1980; Suppl. 19.
Hakama, M.: Maailman terveysjärjestön (WHO) kanta ja suositukset syöpätilastojen laadinnasta. Suomen Tilastoseuran Vuosikirja 1978. Helsinki 1979, pp. 72-73. (in Finnish)
Hakama, M., Pukkala, E. and Saastamoinen, P.: Selective screening: Theory and practise based on high-risk groups of cervical cancer. J. Epidemiol. Community Health 1979; 33: 257-261.
Hakama, M., Soini, I., Kuosma, E., Lehtonen, M. and Aromaa, A.: Breast cancer incidence: Geographical correlations in Finland. Int. J. Epidemiol. 1979; 8: 33-40.
Hakama, M. and Teppo, L.: Syöpätaudit. In: Kansanterveystiede III. Ed. I. Rantasalo and M. Koskenvuo. Lääketieteenkandidaattiseura, Helsinki 1979, pp. 218-231. (in Finnish)
Kiviluoto, R., Meurman, L.O. and Hakama, M.: Pleural plaques and neoplasia in Finland. Ann. N. Y. Acad. Sci. 1979; 330: 31-33.
Louhivuori, K.A. and Hakama, M.: Risk of suicide among cancer patients. Am. J. Epidemiol. 1979; 109: 59-65.
Meurman, L.O., Kiviluoto, R. and Hakama, M.: Combined effects of asbestos exposure and tobacco smoking on Finnish anthophyllite miners and millers. Ann. N. Y. Acad. Sci. 1979; 330: 491-496.
Soini, I. and Hakama, M.: Inverse association between risk factors for benign and malignant breast lesion. Scand. J. Soc. Med. 1979; 7: 79-85.
Hakama, M.: Mass screening for cervical cancer in Finland. In: Screening in cancer. Ed. A.B. Miller. UICC techn. Rep. Ser. Vol. 40. UICC, Geneva 1978, pp. 93-107.
Kauraniemi, T., Räsänen-Virtanen, U. and Hakama, M.: Risk of cervical cancer among an electrocoagulated population. Am. J. Obstet. Gynecol. 1978; 131: 533-538.
Soini, I. and Hakama, M.: Failure of selective screening for breast cancer by combining risk factors. Int. J. Cancer 1978; 22: 275-281.
Hakama, M. and Hakulinen, T.: Estimating the expectation of life in cancer survival studies with incomplete follow-up information. J. Chron. Dis. 1977; 30: 585-597.
Hakama, M. and Pukkala, E.: Selective screening for cervical cancer. Experience of Finnish mass screening system. Brit. J. Prev. Soc. Med. 1977; 31: 238-244.
Aromaa, A., Hakama, M., Hakulinen, T., Saxén, E., Teppo, L. and Idänpään-Heikkilä, J.: Breast cancer and use of rauwolfia and other antihypertensive agents in hypertensive patients: A nationwide case-control study in Finland. Int. J. Cancer 1976; 18: 727-738.
Aromaa, A., Hakama, M., Hakulinen, T., Saxén, E., Teppo, L. and Idänpään-Heikkilä, J.: Rauwolfia and breast cancer. Lancet 1976; II: 518.
Hakama, M.: Keuhkosyövän epidemiologiaa. Suomen Tuberkuloosin Vastustamisyhdistyksen vuosikirja Tuberkuloosi ja keuhkosairaudet 1976; 5: 5-6. (in Finnish)
Hakama, M. and Räsänen-Virtanen, U.: Effect of a mass screening program on the risk of cervical cancer. Am. J. Epidemiol. 1976; 103: 512-517.
Hemminki, E., Hemminki, K., Hakulinen, T. and Hakama, M.: Increase in years after eliminating causes of death: Significance for health priorities. Scand. J. Soc. Med. 1976; 4: 1-6.
Hakama, M.: Keuhkosyövän epidemiologiaa. Syöväntorjunta 1975; No. 2: 8-9. (in Finnish)
Hakama, M., Hakulinen, T., Teppo, L. and Saxén, E.: Incidence, mortality or prevalence as indicators of the cancer problem. Cancer (Philad.) 1975; 36: 2227-2231.
Hakama, M. and Joutsenlahti, U.: Kohdunkaulansyövän hoidon tulokset Suomessa 1953-68. (End-results of patients with carcinoma in situ, or invasive cervical cancer, diagnosed in Finland 1953-1968.) Duodecim 1975; 91: 586-593. (in Finnish, with English summary)
Hakama, M., Joutsenlahti, U., Virtanen A and Räsänen-Virtanen, U.: Mass screenings for cervical cancer in Finland 1963-71. Organization, extent, and epidemiological implications. Ann. Clin. Res. 1975; 7: 101-111.
Hakama, M., Riihimäki, H. and Saxén, E.: Suomessa 1953-68 todettujen rintasyöpäpotilaiden ennuste. (End results of breast cancer patients in Finland 1953-1968.) Duodecim 1975; 91: 266-277. (in Finnish, with English summary)
Hakama, M. and Räsänen-Virtanen, U.: Riskiryhmäseulonnan mahdollisuudet kohdunkaulan syövän joukkotutkimuksissa. (Selective cytological screening for cervical cancer.) Duodecim 1975; 91: 579-585. (in Finnish, with English summary)
Saxén, E. and Hakama, M.: Trends in cancer incidence - facts or fallacy. Studies in Finland. In: Proceedings, XI International Cancer Congress, Florence, 20-26 October 1974. Vol. 3. Ed. P. Bucalossi, U. Veronesi and N. Cascinelli. Excerpta Medica, Amsterdam 1975, pp. 168-174.
Teppo, L., Hakama, M., Hakulinen, T., Lehtonen, M. and Saxén, E.: Cancer in Finland 1953-1970: Incidence, mortality, prevalence. Acta Path. Microbiol. Scand. Sect. A 1975; Suppl. 252.
Hakama, M.: Epidemiologian perusmenetelmät. (Basic methods in epidemiology.) Duodecim 1974; 90: 1507-1513. (in Finnish, with English summary)
Hakama, M. and Riihimäki, H.: End results of breast cancer patients in Finland 1953-1968. Ann. Clin. Res. 1974; 6: 115-121.
Hemminki, E., Hemminki, K., Hakulinen, T. and Hakama, M.: Yleisimpien kuolemansyiden vaikutus suomalaisen väestön elinvuosiin. (Demographic effects of the elimination of selected causes of death in Finland.) Duodecim 1974; 90: 1167-1179. Oikaisu Duodecim 1974: 90: 1483-1488. (in Finnish, with English summary)
Meurman, L.O., Kiviluoto, R. and Hakama, M.: Mortality and morbidity among the working population of anthophyllite asbestos miners in Finland. Br. J. Ind. Med. 1974; 31: 105-112.
Saxén, E., Hakama, M. and Teppo, L.: Syöpätautien epidemiologinen tutkimus. (Epidemiological cancer research.) Duodecim 1974; 90: 1597-1604. (in Finnish, with English summary)
Teppo, L. and Hakama, M.: Reserpiini ja rintasyöpä. Duodecim 1974; 90: 1637-1641. (in Finnish)
Teppo, L., Hakama, M., Hakulinen, T. and Saxén, E.: Insidenssi, mortaliteetti ja prevalenssi syöpätautien yleisyyden mittana. (Incidence, mortality and prevalence as indicators of the cancer problem.) Duodecim 1974; 90: 1541-1547. (in Finnish, with English summary)
Hakama, M.: Hoitotutkimusten biometrisia periaatteita ja keinoja. (Therapeutic trials.) Duodecim 1973; 89: 1421-1430. (in Finnish, with English summary)
Hakama, M., Franssila, K. and Saxén, E.: Reliability of histopathologic diagnosis of malignant lymphoma. Ann. Clin. res. 1973; 5: 104-108.
Meurman, L.O., Kiviluoto, R. and Hakama, M.: Mortality and morbidity of employees of anthophyllite asbestos mines in Finland. In: Biological effects of asbestos. Proceeding of a working conference held at the International Agency for Research on Cancer, Lyon, France, 2-6 October 1972. Ed. P. Bogovski. IARC Scientific Publications No. 8. International Agency for Research on Canc
Myllärniemi, S., Kleemola-Kujala, E. and Hakama, M.: Oral and dental state in Helsinki preschool children IV. Caries incidence in the deciduous dentition. Proc. Finn. Dent. Soc. 1973; 69: 151-156.
Hakama, M.: Syöpätautien epidemiologia. Sosiaalilääketiet. Aik.-L. 1972; 10: 306-312. (in Finnish)
Hakama, M.: Trends in stomach cancer incidence for male cohorts in Finland. Ann. Clin. Res. 1972; 4: 300-303.
Hakama, M.: Age-adjustment of incidence rates in cancer epidemiology. In: Yearbook of Cancer 1971. Ed. Clark and Cumley. Yearbook Medical Publishers, Chicago 1971.
Hakama, M.: Cancerföreningens i Finland enkät angående läkarkårens tobaksvanor. I: Cancerorganisationernas verksamhetsberättelse, 1970. K.J. Gummerus Oy, Jyväskylä 1971, p. 92-95. (in Swedish)
Hakama, M.: Epidemiologic evidence for multi-stage theory of carcinogenesis. Int. J. Cancer 1971; 7: 557-564.
Hakama, M.: Lääkärien tupakointitavat. Suom. Lääk.-L. 1971; 26: 1205-1207. (in Finnish)
Hakama, M.: Tupakka ja hengityselinten syöpäsairaudet. Suom. Lääk.-L. 1971; 26: 38-43. (in Finnish)
Saxén, E. and Hakama, M.: Tobak och lung cancer. I: Cancerorganisationernas verksamhetsberättelse 1969. K.J. Gummerus Oy, Jyväskylä 1971, p. 85-102. (in Swedish)
Hakama, M.: Age-adjustment of incidence rates in cancer epidemiology. Acta Path. Microbiol. Scand. Sect. A 1970; Suppl. 213.
Hakama, M.: Kohdunkaulan syöpä ja joukkotarkastukset. (Effect of mass screening program on incidence of cervical cancer in Finland.) Duodecim 1970; 86: 270-276. (in Finnish, with English summary)
Hakama, M.: Kohdunkaulan syöpä ja joukkotarkastukset. Kirje toimittajalle. Duodecim 1970; 86: 528-535. (in Finnish)
Kreus, K.-E., Hakama, M. and Saxén, E.: Association of pulmonary tuberculosis and carcinoma of the lung. Scand. J. Resp. Dis. 1970; 51: 276-289.
Saxén, E. and Hakama, M.: Tupakka ja keuhkosyöpä. (Smoking and lung cancer.) Duodecim 1970; 86: 426-445. (in Finnish)
Antila, J., Hakama, M. and Saxén, E.A.: Report on survival rates of some histologically confirmed cancer cases in Finland in 1959-60. COINTRA, 11eme Conference Internationale. Rome, 30 septembre - 4 octobre 1969. Consorzio Italiano per L'assicurazione Vita Dei Rischi Tarati, Rome 1969.
Hakama, M.: Different world thyroid cancer rates. In: Thyroid cancer. UICC Monograph Series. Vol. 12. Ed. C. Hedinger. Springer-Verlag, Berlin 1969, pp. 66-71.
Hakama, M.: The peculiar age specific incidence curve for cancer of the breast - Clemmesen's hook. Acta Path. Microbiol. Scand. 1969; 75: 370-374.
Pedersen, E., Magnus, K., Mork, T., Hougen, A., Bjelke, E., Hakama, M. and Saxén, E.: Lung cancer in Finland and Norway, An epidemiological study. Acta Path. Microbiol. Scand. 1969; Suppl. 199.
Saxén, E.A., Franssila, K. and Hakama, M.: Effect of histological typing of registry material on the results of epidemiological comparisons in thyroid cancer. In: Thyroid cancer. UICC Monograph Series. Vol. 12. Ed. C. Hedinger. Springer-Verlag, Berlin 1969, pp. 98-103.
Saxén, E.A., Franssila, K. and Hakama, M.: Undifferentiated carcinomas. In. Thyroid cancer. UICC Monograph Series. Vol. 12. Ed. C. Hedinger. Springer-Verlag, Berlin 1969, pp. 44-46.
Saxén, E., Hakama, M. and Lehtonen, M.: Cancer in Finland 1954-63. Ann. Clin. Res. 1969; 1: 291-300.
Hakama, M.: Syövän hoitotulosten mittaamisen perusteet. Kirje toimittajalle. Duodecim 1968; 84: 224-225. (in Finnish)
Saxén, L., Cantell, K. and Hakama, M.: Isorokkorokotus ja raskaus. Esimerkki epidemiologisen tutkimuksen mahdollisuuksista ja rajoituksista. (Smallbox vaccination and pregnancy.) Duodecim 1968; 84: 921-930. (in Finnish)
Saxén, L., Cantell, K. and Hakama, M.: Relation between smallpox vaccination and outcome of pregnancy. Am. J. Public Health 1968; 58: 1910-1921.
Hakama, M.: Syövän hoitotulosten vertailun vaikeuksia. (Surgery with and without radiation in cancer treatment.) Duodecim 1967; 83: 1275-1279. (in Finnish, with English summary)
Hakama, M. and Saxén, E.: Epidemiologinen syöpätutkimus. (Epidemiological cancer research.) Duodecim 1967; 83: 201-206. (in Finnish, with English summary)
Hakama, M. and Saxén, E.A.: Cereal consumption and gastric cancer. Int. J. Cancer 1967; 2: 265-268.
Saxen, E. and Hakama, M.: The different incidence of gastric cancer all over the world and possible reasons for this difference. In: UICC Monograph Series. Vol 10: Ninth International Cancer Congress. Ed. J. C. Harris. New York 1967, p.49-55.
Saxén, E. and Hakama, M.: Syöpätautien yleisyys. (Cancer incidence.) Duodecim 1967; 83: 192-200. (in Finnish)
Saxén, E.A. and Hakama, M.: The different incidence of gastric cancer all over the world and possible reasons for this difference. UICC Monograph Series. Vol. 10: Ninth International Cancer Congress. Ed. R. J. J. Harris. Springer-Verlag, Berlin 1967, pp. 49-55.
Saxén, E. and Hakama, M.: Cancer incidence in Finland with a note on difficulties in comparing epidemiological data. Il Cancro 1966; 19: No. 2.
Saxén, E. and Hakama, M.: Finland. In: Cancer Incidence in Five Continents. A technical report. Ed. R. Doll, P. Payne and J. Waterhouse. International Union Against Cancer. Springer-Verlag, Berlin 1966, pp. 158-163.
Hakama, M.: Tupakka ja keuhkosyöpä. In: Suomen Syöpäyhdistyksen ja Syöpäsäätiön toimintakertomus vuodelta 1964, p. 66-68 (1965). (in Finnish)
Saxén, E. and Hakama, M.: Cancer registration in Finland with a note on the "dangers" of early diagnosis. Proceedings of the European and Extra-European seminarium for cancer prophylaxis and prevention. Centro Sociale Studio Precancerosi, Universita di Roma, 17-19 Settembre 1965.
Saxén, E. and Hakama, M.: Syövän leikkaus- ja sädehoidon vertailua eloonjäämislukujen perusteella. (Surgery and/or radiation in the treatment of cancer. End-result studies.) Duodecim 1965; 81: 569-573. (in Finnish, with English summary)
Hakama, M.: Rintasyövän hoidon tuloksista Suomessa 1953-56 Syöpärekisterin aineiston valossa. Hoidon tulosten määrittäminen eloonjäämistodennäköisyyden avulla. (Results of the treatment of breast cancer in Finland 1953-56.) Duodecim 1964; 80: 348-360. (in Finnish, with English summary)
Hakama, M. and Saxén, E.: Keuhkosyöpäkuolleisuuden nousuun vaikuttavista tekijöistä. (Factors affecting the increase of lung cancer morbidity in Finland. ) Duodecim 1964; 80: 781-785. (in Finnish, with English summary)
Saxén, E. and Hakama, M.: Cancer illness in Finland. With a note on the effects of age adjustment and early diagnosis. Ann. Med. Exp. Biol. Fenn. 1964; 42: Suppl. 2.
Saxén, E. and Hakama, M.: Cancer registration in Finland. Wld Med. J. 1964; 177-180.
Saxén, E. and Hakama, M.: End results studies on cancer of the ovary. In: International Symposium on End Results of Cancer Therapy. Ed. S.J. Culter. Nat. Cancer Inst. Monogr. 1964; No. 15: 135-147.
Hakama, M.: Syövän hoitotulosten mittaamisesta. (Estimation of end results in cancer.) Duodecim 1963; 79: 393-400. (in Finnish, with English summary)
Saxén, E. and Hakama, M.: Tilastollisesta syöpätutkimuksesta. Suomen Syöpärekisteri ja sen toiminta. (Statistical cancer research. The Finnish Cancer Register and its function.) Duodecim 1963; 79: 385-392. (in Finnish, with English summary)
Vainio, T., Hakama, M. and Saxén, E.: Suomessa 1953-1956 todettujen histologisesti vahvistettujen syöpätapausten eloonjäämisluvuista. (Survival experience of patients with cancer in Finland, 1953-1956.) Suomen Syöpäyhdistyksen ja Syöpäsäätiön toimintakertomus ajalta 1.7.1961 - 30.6. 1962, p. 46-51. (in Finnish, with English summary)
Vainio, T., Hakama, M. and Saxén, E.: Suomessa 1953-1956 todettujen histologisesti vahvistettujen syöpätapausten eloonjäämisluvuista. (Survival experience of patients with cancer in Finland, 1953-1956.) Duodecim 1963; 79: 38-42. (in Finnish, with English summary)